Complete Publication List for Rohit Bhargava, M.D.

Refereed Articles (Published)

• Ling DC, Sutera PA, Iarrobino NA, Diego EJ, Soran A, Johnson RR, Bhargava R, Champ CE, Beriwal S. Is multifocal regression a risk factor for ipsilateral breast tumor recurrence in the modern era after neoadjuvant chemotherapy and breast conservation therapy? Int J Radiat Oncol Biol Phys. 2019;104:869-876. PMID: 30885777.

• Min Han, Arsalan Salamat, Li Zhu, Huina Zhang, Beth Z Clark, David J Dabbs, Gloria J Carter, Adam M Brufsky, Rachel C Jankowitz, Shannon L Puhalla, Ronald R Johnson, Atilla Soran, Jennifer G Steiman, Priscilla F McAuliffe, Emilia J Diego, Rohit Bhargava. Metaplastic breast carcinoma: A clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapy. Mod Pathol. 2019;32:807-816. PMID: 30723293.

• Beth Clark, Agnieszka Onisko, Binara Assylbekova, Xin Li, Rohit Bhargava, David Dabbs. Breast Cancer Global Tumor Biomarkers: A Quality Assurance Study of Intratumoral Heterogeneity. Mod Pathol. 2019;32:354-366. PMID: 30327501.

• Hugar S, Bhargava R, Dabbs DJ, Clark BZ. Isolated Flat Epithelial Atypia on Core Biopsy is Associated with a Low Risk of Upgrade at Excision. Am J Clin Pathol.2019;151:511-515. PMID: 30753261.

• Rohit Bhargava, Beth Z Clark, David J Dabbs. Breast cancers with Magee Equations score of less than 18, or 18-25 and mitosis score of 1 do not require oncotype DX® testing: A Value Study. Am J Clin Pathol. 2019;151:316-323. PMID: 30395177.

• Basudan A, Priedigkeit N, Hartmaier RJ, Sokol ES, Bahreini A, Watters RJ, Boisen MM, Bhargava R, Weiss KR, Karsten MM, Denkert C, Blohmer JU, Leone JP, Hamilton RL, Brufsky AM, Elishaev E, Lucas PC, Lee AV, Oesterreich S. Frequesnt ESR1 and CDK Pathway Copy Number Alterations in Metastatic Breast Cancer. Mol Cancer Res. 2019;17:457-468. PMID: 30355675.

• Yu YP, Liu P, Nelson J, Hamilton RL, Bhargava R, Michalopoulos G, Chen Q, Zhang J, Ma D, Pennathur A, Luketich J, Nalesnik M, Tseng G, Luo JH. Identification of recurrent fusion genes across multiple cancer types. Sci Rep. 2019;9:1074. PMID: 30705370.

• Michael J Dohopolski, MD; Zachary D Horne, MD; Dinesh Pradhan, MD; Rohit Bhargava, MD; Robert P Edwards, MD; Joseph L Kelley, MD; John T Comerci, MD; Alexander B Olawaiye, MD; Madeleine B Courtney-Brooks, MD; Michelle M Bockmeier, MD; Jessica L Berger, MD; Paniti Sukumvanich, MD, PhD, Sushil Beriwal, MD. The prognostic significance of p16 status in patients with vulvar cancer treated with vulvectomy and adjuvant radiation. International Journal of Radiation Oncology, Biology, Physics. 2019;103:152-160. PMID: 30121234.

• Huina Zhang, Min Han, Kavita R Varma, Beth Z Clark, Rohit Bhargava, David J Dabbs. High Fidelity of Breast Biomarker Metrics: A 10-Year Experience in a Single, Large

Academic Institution. Applied Immunohistochem Mol Morphol. 2018;26:697-700. PMID: 30095467.

• Zachary D Horne, MD; Michael J Dohopolski, MD; Dinesh Pradhan, MD; Rohit Bhargava, MD; Robert P Edwards, MD; Joseph L Kelley, MD; John T Comerci, MD; Alexander B Olawaiye, MD; Madeleine B Courtney-Brooks, MD; Michelle M Bockmeier, MD; Jessica L Berger, MD; Sarah E Taylor, MD; Paniti Sukumvanich, MD, PhD, Sushil Beriwal, MD. Human papillomavirus infection mediates response and outcome of vulvar squamous cell carcinomas treated with chemoradiation therapy. Gynecol Oncol. 2018;151:96-101. PMID: 30082072.

• Dabbs DJ, Clark BZ, Serdy K, Onisko A, Brufsky A, Smalley S, Perkins S, Bhargava R. Pathologist’s health care value in the triage of Oncotype DX testing: A value-based pathology study of tumor biology with outcomes. Histopathology. 2018;73:692-700. PMID: 29920746.

• Landmann A, Farrugia DJ, Zhu L, Diego EJ, Johnson R, Soran A, Dabbs DJ, Clark BZ, Puhalla SL, Jankowitz RC, Brufsky AM, Ahrendt GM, McAuliffe PF, Bhargava R. Low estrogen receptor (ER) positive breast cancer and neoadjuvant systemic chemotherapy: Is response similar to typical ER positive or ER negative disease? Am J Clin Pathol. 2018;150:34-42. PMID: 29741562.

• Clark BZ, Farrugia DJ, Landmann A, Diego EJ, Dabbs DJ, Puhalla SL, Jankowitz RC, Brufsky AM, Ahrendt GM, McAuliffe PF, Bhargava R. Prognostic Significance of Modified Residual Disease in Breast and Nodes (mRDBN) Algorithm After Neoadjuvant Chemotherapy for Breast Cancer. Am J Clin Pathol. 2018;149(4):332-343. PMID: 29481634.

• Synchronous bilateral tubal serous carcinomas in a patient with exon 13 duplication and loss of function of BRCA1. Gurda GT, Serdy KM, Yatsenko SA, Rajkovic A, Carter NJ, Ahmed R, Olawaiye AB, Bhargava R, Elishaev E. Int J Gynecol Pathol. 2018;37:117-122. PMID: 28463906.

• Binara Assylbekova, Esther Elishaev, and Rohit Bhargava. Well differentiated endometrioid adenocarcinoma of the endometrium with “adenoma malignum-like” pattern of invasion: Report of two cases and review of literature. Ann Clin Lab Sci. 2017;47:765-767. PMID: 29263054.

• Chen ZH, Yu YP, Tao J, Liu S, Tseng G, Nalesnik M, Hamilton R, Bhargava R, Nelson JB, Pennathur A, Monga SP, Luketich JD, Michalopoulos GK, Luo JH. MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice. Gastroenterology. 2017;153:1120-1132. PMID: 28245430.

• Priedigkeit N, Watters RJ, Lucas PC, Basudan A, Bhargava R, Horne W, Kolls JK, Fang Z, Rosenzweig MQ, Brufsky AM, Weiss KR, Oesterreich S, Lee AV. Exome-capture RNA sequencing of decade-old breast cancers and matched decalcified bone metastases. JCI Insight. 2017 Sep 7;2(17). pii: 95703. PMID: 28878133.

• Assylbekova B, Kanbour-Shakir A, Varma K, Bhargava R, Elishaev E. Primary Pure Endometrial Primitive Neuroectodermal Tumors with EWSR1 Gene Rearrangement: Report of 2 Cases. Ann Clin Lab Sci. 2017 Aug;47(4):474-476. PMID: 28801375.

https://www.ncbi.nlm.nih.gov/pubmed/?term=Landmann%20A%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=Farrugia%20DJ%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=Diego%20EJ%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=Dabbs%20DJ%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=Clark%20BZ%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=Puhalla%20SL%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=Jankowitz%20RC%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=Brufsky%20AM%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=Ahrendt%20GM%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=McAuliffe%20PF%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=Bhargava%20R%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=Clark%20BZ%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=Farrugia%20DJ%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=Landmann%20A%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=Diego%20EJ%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=Dabbs%20DJ%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=Puhalla%20SL%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=Jankowitz%20RC%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=Brufsky%20AM%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=Brufsky%20AM%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=Ahrendt%20GM%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=McAuliffe%20PF%5BAuthor%5D&cauthor=true&cauthor_uid=29481634https://www.ncbi.nlm.nih.gov/pubmed/?term=Chen%20ZH%5BAuthor%5D&cauthor=true&cauthor_uid=28245430https://www.ncbi.nlm.nih.gov/pubmed/?term=Yu%20YP%5BAuthor%5D&cauthor=true&cauthor_uid=28245430https://www.ncbi.nlm.nih.gov/pubmed/?term=Tao%20J%5BAuthor%5D&cauthor=true&cauthor_uid=28245430https://www.ncbi.nlm.nih.gov/pubmed/?term=Liu%20S%5BAuthor%5D&cauthor=true&cauthor_uid=28245430https://www.ncbi.nlm.nih.gov/pubmed/?term=Tseng%20G%5BAuthor%5D&cauthor=true&cauthor_uid=28245430https://www.ncbi.nlm.nih.gov/pubmed/?term=Nalesnik%20M%5BAuthor%5D&cauthor=true&cauthor_uid=28245430https://www.ncbi.nlm.nih.gov/pubmed/?term=Hamilton%20R%5BAuthor%5D&cauthor=true&cauthor_uid=28245430https://www.ncbi.nlm.nih.gov/pubmed/?term=Bhargava%20R%5BAuthor%5D&cauthor=true&cauthor_uid=28245430https://www.ncbi.nlm.nih.gov/pubmed/?term=Nelson%20JB%5BAuthor%5D&cauthor=true&cauthor_uid=28245430https://www.ncbi.nlm.nih.gov/pubmed/?term=Pennathur%20A%5BAuthor%5D&cauthor=true&cauthor_uid=28245430https://www.ncbi.nlm.nih.gov/pubmed/?term=Monga%20SP%5BAuthor%5D&cauthor=true&cauthor_uid=28245430https://www.ncbi.nlm.nih.gov/pubmed/?term=Luketich%20JD%5BAuthor%5D&cauthor=true&cauthor_uid=28245430https://www.ncbi.nlm.nih.gov/pubmed/?term=Michalopoulos%20GK%5BAuthor%5D&cauthor=true&cauthor_uid=28245430https://www.ncbi.nlm.nih.gov/pubmed/?term=Luo%20JH%5BAuthor%5D&cauthor=true&cauthor_uid=28245430

• Farrugia DJ, Landmann A, Zhu L, Diego EJ, Johnson RR, Bonaventura M, Soran A, Dabbs DJ, Clark BZ, Puhalla SL, Jankowitz RC, Brufsky AM, Lembersky BC, Ahrendt GM, McAuliffe PF, Bhargava R. Magee Equation 3 predicts pathologic response to neoadjuvant systemic chemotherapy in estrogen receptor positive, HER2 negative/equivocal breast tumors. Mod Pathol. 2017 Aug;30(8):1078-1085. PMID: 28548119.

• Bhargava R, Dabbs DJ. Magee equations and oncotype DX®-a perspective. Breast Cancer Res Treat. 2017 Jul;164(1):245-246. PMID: 28393310.

• Gurda GT, Ambros T, Nikiforova MN, Nikiforov YE, Lucas PC, Dabbs DJ, Lee AV, Brufsky AM, Puhalla SL, Bhargava R. Characterizing molecular variants and clinical utilization of next-generation sequencing in advanced breast cancer. Appl Immunohistochem Mol Morphol. 2017;25:392-398. PMID: 26862949.

• Priedigkeit N, Hartmaier RJ, Chen Y, Vareslija D, Basudan A, Watters RJ, Thomas R, Leone JP, Lucas PC, Bhargava R, Hamilton RL, Chmielecki J, Puhalla SL, Davidson NE, Oesterreich S, Brufsky AM, Young L, Lee AV. Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases. JAMA Oncol. 2017;3:666-671. PMID: 27926948.

• Bhargava R, Florea AV, Pelmus M, Jones MW, Bonaventura M, Wald A, Nikiforova M. Breast tumor resembling tall cell variant of papillary thyroid carcinoma: A solid papillary neoplasm with characteristic immunohistochemical profile and few recurrent mutations. Am J Clin Pathol. 2017;147:399-410. PMID: 28375433.

• Han K, Li X, Bhargava R, Taylor S, Lee K, Yadav D. Polypoid Endometriosis Presenting as a Colonic Mass. ACG Case Rep J. 2017 Mar 15;4:e39. doi: 10.14309/crj.2017.39. eCollection 2017. PMID: 28331878.

• Panebianco F, Kelly LM, Liu P, Zhong S, Dacic S, Wang X, Singhi AD, Dhir R, Chiosea SI, Kuan SF, Bhargava R, Dabbs D, Trivedi S, Gandhi M, Diaz R, Wald AI, Carty SE, Ferris RL, Lee AV, Nikiforova MN, Nikiforov YE. THADA fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer. Proc Natl Acad Sci. 2017;114:2307-2312. PMID: 28193878.

• Kate M Serdy, José Pablo Leone, David J Dabbs, Rohit Bhargava. Male Breast Cancer: A Single Institution Clinicalpathologic and Immunohistochemical Study. Am J Clin Pathol. 2017;147:110-119. PMID: 28122723.

• Chunyu Cao, Shauna Vasilatos, Rohit Bhargava, Jeffrey L. Fine, Steffi Oesterreich, Nancy E. Davidson, and Yi Huang. Functional Interaction of Histone Deacetylase 5 (HDAC5) and Lysine-specific Demethylase 1 (LSD1) Promotes Breast Cancer Progression. Oncogene. 2017;36:133-145. PMID: 27212032.

• Gyanchandani R, Lin Y, Lin HM, Cooper KL, Normolle DP, Brufsky AM, Fastuca M, Crosson W, Oesterreich S, Davidson NE, Bhargava R, Dabbs DJ, Lee AV. Intra-tumor heterogeneity affects gene expression profile test prognostic risk stratification in early breast cancer. Clin Cancer Res. 2016;22:5362-5369. PMID: 27185370.

• Erica R Ghareeb, Rohit Bhargava, John A Vargo, Anca V Florea, and Sushil Beriwal, MD. Primary and Radiation Induced Breast Angiosarcoma: Clinicopathological Predictors of

https://www.ncbi.nlm.nih.gov/pubmed/27926948https://www.ncbi.nlm.nih.gov/pubmed/27926948https://www.ncbi.nlm.nih.gov/pubmed/?term=Han%20K%5BAuthor%5D&cauthor=true&cauthor_uid=28331878https://www.ncbi.nlm.nih.gov/pubmed/?term=Li%20X%5BAuthor%5D&cauthor=true&cauthor_uid=28331878https://www.ncbi.nlm.nih.gov/pubmed/?term=Bhargava%20R%5BAuthor%5D&cauthor=true&cauthor_uid=28331878https://www.ncbi.nlm.nih.gov/pubmed/?term=Taylor%20S%5BAuthor%5D&cauthor=true&cauthor_uid=28331878https://www.ncbi.nlm.nih.gov/pubmed/?term=Lee%20K%5BAuthor%5D&cauthor=true&cauthor_uid=28331878https://www.ncbi.nlm.nih.gov/pubmed/?term=Yadav%20D%5BAuthor%5D&cauthor=true&cauthor_uid=28331878https://www.ncbi.nlm.nih.gov/pubmed/28331878https://www.ncbi.nlm.nih.gov/pubmed/?term=Panebianco%20F%5BAuthor%5D&cauthor=true&cauthor_uid=28193878https://www.ncbi.nlm.nih.gov/pubmed/?term=Kelly%20LM%5BAuthor%5D&cauthor=true&cauthor_uid=28193878https://www.ncbi.nlm.nih.gov/pubmed/?term=Liu%20P%5BAuthor%5D&cauthor=true&cauthor_uid=28193878https://www.ncbi.nlm.nih.gov/pubmed/?term=Zhong%20S%5BAuthor%5D&cauthor=true&cauthor_uid=28193878https://www.ncbi.nlm.nih.gov/pubmed/?term=Dacic%20S%5BAuthor%5D&cauthor=true&cauthor_uid=28193878https://www.ncbi.nlm.nih.gov/pubmed/?term=Wang%20X%5BAuthor%5D&cauthor=true&cauthor_uid=28193878https://www.ncbi.nlm.nih.gov/pubmed/?term=Singhi%20AD%5BAuthor%5D&cauthor=true&cauthor_uid=28193878https://www.ncbi.nlm.nih.gov/pubmed/?term=Dhir%20R%5BAuthor%5D&cauthor=true&cauthor_uid=28193878https://www.ncbi.nlm.nih.gov/pubmed/?term=Chiosea%20SI%5BAuthor%5D&cauthor=true&cauthor_uid=28193878https://www.ncbi.nlm.nih.gov/pubmed/?term=Kuan%20SF%5BAuthor%5D&cauthor=true&cauthor_uid=28193878https://www.ncbi.nlm.nih.gov/pubmed/?term=Bhargava%20R%5BAuthor%5D&cauthor=true&cauthor_uid=28193878https://www.ncbi.nlm.nih.gov/pubmed/?term=Dabbs%20D%5BAuthor%5D&cauthor=true&cauthor_uid=28193878https://www.ncbi.nlm.nih.gov/pubmed/?term=Trivedi%20S%5BAuthor%5D&cauthor=true&cauthor_uid=28193878https://www.ncbi.nlm.nih.gov/pubmed/?term=Gandhi%20M%5BAuthor%5D&cauthor=true&cauthor_uid=28193878https://www.ncbi.nlm.nih.gov/pubmed/?term=Diaz%20R%5BAuthor%5D&cauthor=true&cauthor_uid=28193878https://www.ncbi.nlm.nih.gov/pubmed/?term=Wald%20AI%5BAuthor%5D&cauthor=true&cauthor_uid=28193878https://www.ncbi.nlm.nih.gov/pubmed/?term=Carty%20SE%5BAuthor%5D&cauthor=true&cauthor_uid=28193878https://www.ncbi.nlm.nih.gov/pubmed/?term=Ferris%20RL%5BAuthor%5D&cauthor=true&cauthor_uid=28193878https://www.ncbi.nlm.nih.gov/pubmed/?term=Lee%20AV%5BAuthor%5D&cauthor=true&cauthor_uid=28193878https://www.ncbi.nlm.nih.gov/pubmed/?term=Nikiforova%20MN%5BAuthor%5D&cauthor=true&cauthor_uid=28193878https://www.ncbi.nlm.nih.gov/pubmed/?term=Nikiforov%20YE%5BAuthor%5D&cauthor=true&cauthor_uid=28193878https://www.ncbi.nlm.nih.gov/pubmed/28193878http://www.ncbi.nlm.nih.gov/pubmed/?term=Gyanchandani%20R%5BAuthor%5D&cauthor=true&cauthor_uid=27185370http://www.ncbi.nlm.nih.gov/pubmed/?term=Lin%20Y%5BAuthor%5D&cauthor=true&cauthor_uid=27185370http://www.ncbi.nlm.nih.gov/pubmed/?term=Lin%20HM%5BAuthor%5D&cauthor=true&cauthor_uid=27185370http://www.ncbi.nlm.nih.gov/pubmed/?term=Cooper%20KL%5BAuthor%5D&cauthor=true&cauthor_uid=27185370http://www.ncbi.nlm.nih.gov/pubmed/?term=Normolle%20DP%5BAuthor%5D&cauthor=true&cauthor_uid=27185370http://www.ncbi.nlm.nih.gov/pubmed/?term=Brufsky%20AM%5BAuthor%5D&cauthor=true&cauthor_uid=27185370http://www.ncbi.nlm.nih.gov/pubmed/?term=Fastuca%20M%5BAuthor%5D&cauthor=true&cauthor_uid=27185370http://www.ncbi.nlm.nih.gov/pubmed/?term=Crosson%20W%5BAuthor%5D&cauthor=true&cauthor_uid=27185370http://www.ncbi.nlm.nih.gov/pubmed/?term=Oesterreich%20S%5BAuthor%5D&cauthor=true&cauthor_uid=27185370http://www.ncbi.nlm.nih.gov/pubmed/?term=Davidson%20NE%5BAuthor%5D&cauthor=true&cauthor_uid=27185370http://www.ncbi.nlm.nih.gov/pubmed/?term=Bhargava%20R%5BAuthor%5D&cauthor=true&cauthor_uid=27185370http://www.ncbi.nlm.nih.gov/pubmed/?term=Dabbs%20DJ%5BAuthor%5D&cauthor=true&cauthor_uid=27185370http://www.ncbi.nlm.nih.gov/pubmed/?term=Lee%20AV%5BAuthor%5D&cauthor=true&cauthor_uid=27185370

Outcomes and the Impact of Adjuvant Radiation Therapy. American Journal of Clinical Oncology. 2016;39:463-467. PMID: 25521258.

• Soran A, Bhargava R, Johnson R, Ahrendt G, Bonaventura M, Diego E, McAuliffe PF, Serrano M, Menekse E, Sezgin E, McGuire KP. The impact of Oncotype DX® recurrence score of paraffin-embedded core biopsy tissues in predicting response to neoadjuvant chemotherapy in women with breast cancer. Breast Dis. 2016;36:65-71. PMID: 27662272.

• Bhargava R, Davidson NE. "Take two"? The role of second opinions for breast biopsy specimens. BMJ. 2016; June 23, 353;i3256. PMID: 27339037.

• José Pablo Leone, MD; Ariel Osvaldo Zwenger, MD, PhD, Julián Iturbe, MD; Julieta Leone, MD; Bernardo Amadeo Leone, MD; Carlos Teodoro Vallejo, MD and Rohit Bhargava, MD. Prognostic Factors in Male Breast Cancer: A Population-Based Study. Breast Cancer Research and Treatment. 2016;156:539-548. PMID: 27039306.

• Tuna Toptan, Samuel A. Yousem, Jonhan Ho, Yuki Matsushima, Laura P. Stabile, Maria-Teresa Fernández-Figueras, Rohit Bhargava, Akihide Ryo, Patrick S. Moore, Yuan Chang. Survey of human Polyomaviruses in cancer. JCI Insight. 2016;1(2):e85562. doi: 10.1172/jci.insight.85562.

• Brown DD, Dabbs DJ, Lee AV, McGuire KP, Ahrendt GM, Bhargava R, Davidson NE, Brufsky AM, Johnson RR, Oesterreich S, McAuliffe PF. Developing in-vitro models of human ductal carcinoma in-situ from primary tissue explants. Breast Cancer Res Treat. 2015;17:104. PMID: 26251034.

• Jose P Leone, Rohit Bhargava, Brian K Theisen, Ron Hamilton, Adrian Lee, Adam Brufsky. Expression of high affinity folate receptor in breast cancer brain metastasis. Oncotarget. 2015;6:30327-33. PMID: 26160847.

• Serena Liao, Ryan Hartmaier, Kandace McGuire, Shannon Puhalla, Soumya Luthra, Uma Chandran, Tianzhou Ma, Rohit Bhargava, Francesmary Modugno, Nancy Davidson, Steve Benz, Adrian Lee, George Tseng, Steffi Oesterreich. The molecular landscape of premenopausal breast cancer. Breast Cancer Research. 2015;17:104. PMID: 26251034.

• Wu Q, Madany P, Akech J, Dobson JR, Douthwright S, Browne G, Colby JL, Winter GE, Bradner JE, Pratap J, Sluder G, Bhargava R, Chiosea S, van Wijnen AJ, Stein JL, Stein GS, Lian JB, Nickerson JA, Imbalzano AN. The SWI/SNF ATPases are required for triple negative breast cancer cell proliferation. J Cell Physiol. 2015;230:2683-2694. PMID: 25808524.

• David M. Gau, Jamie L. Lesnock, Brian L. Hood, Rohit Bhargava, Mai Sun, Kathleen Darcy, Soumya Luthra, Uma Chandran, Thomas P. Conrads, Robert P. Edwards, Joseph L. Kelley, Thomas C. Krivak, Partha Roy. BRCA1 deficiency in ovarian cancer is associated with alteration in expression of 3 several key regulators of cell motility – A proteomics study. Cell Cycle. 2015;14:1884-1892. PMID: 25927284.

• Nika C Gloyeske, Anna H Woodard, Esther Elishaev, Jing Yu, Beth Z Clark, David J Dabbs, Rohit Bhargava. Immunohistochemical profile of breast cancer with respect to Estrogen

/pubmed/?term=Soran%20A%5BAuthor%5D&cauthor=true&cauthor_uid=27662272/pubmed/?term=Bhargava%20R%5BAuthor%5D&cauthor=true&cauthor_uid=27662272/pubmed/?term=Johnson%20R%5BAuthor%5D&cauthor=true&cauthor_uid=27662272/pubmed/?term=Ahrendt%20G%5BAuthor%5D&cauthor=true&cauthor_uid=27662272/pubmed/?term=Bonaventura%20M%5BAuthor%5D&cauthor=true&cauthor_uid=27662272/pubmed/?term=Diego%20E%5BAuthor%5D&cauthor=true&cauthor_uid=27662272/pubmed/?term=McAuliffe%20PF%5BAuthor%5D&cauthor=true&cauthor_uid=27662272/pubmed/?term=Serrano%20M%5BAuthor%5D&cauthor=true&cauthor_uid=27662272/pubmed/?term=Menekse%20E%5BAuthor%5D&cauthor=true&cauthor_uid=27662272/pubmed/?term=Sezgin%20E%5BAuthor%5D&cauthor=true&cauthor_uid=27662272/pubmed/?term=McGuire%20KP%5BAuthor%5D&cauthor=true&cauthor_uid=27662272

Receptor and HER2 status. Appl Immunohistochem Mol Morphol. 2015;23:202-208. PMID: 25356941.

• Zaibo Li, David J Dabbs, Kristine L Cooper, and Rohit Bhargava. Dual HER2 gene protein assay: Focused study of breast cancers with 2+ immunohistochemical expression. Am J Clin Pathol. 2015;143:451-458. PMID: 25696805.

• Haihui Lu, Karl Clauser, Wai Leong Tam, Julia Frose, Xin Ye, Elinor Eaton, Ferenc Reinhardt, Vera Donnenberg, Rohit Bhargava, Steven Carr, and Robert Weinberg [Paper #NCB-W26299D]. A Breast Cancer Stem Cell Niche Supported by Juxtacrine Signaling from Monocytes and Macrophages. Nature Cell Biology. 2014;16:1105-1117. PMID: 25266422.

• Ding Z., Joy M.., Bhargava R., Gunsaulus M., Lakshman N., Miron-Mendoza M., Petroll M., Condeelis J., Wells A., Roy P. Profilin-1 downregulation has contrasting effects on early vs late steps of breast cancer metastasis. Oncogene. 2014;33:2065-2074. PMID: 23686314.

• Rohit Bhargava, and David J Dabbs. Interpretation Of HER2 In-Situ Hybridization Assays Using ASCO/CAP HER2 Guidelines 2013 Update. J Clin Oncol. 2014;32:1855. PMID: 24778404.

• Bhargava R. Clinical utility of immunohistochemistry and other ancillary techniques in assessment of uterine tumors. Semin Diagn Pathol. 2014;31:193-194. PMID: 24933036.

• Beth Z Clark, Surabhi Beriwal, David J Dabbs, Rohit Bhargava. Semiquantitative GATA-3 Immunoreactivity in Breast, Bladder, Gynecologic Tract, and other Cytokeratin 7 Positive Carcinomas. Am J Clin Pathol. 2014;142:64-71. PMID: 24926087.

• Nika C Gloyeske, David J Dabbs, Rohit Bhargava. Low ER+ Breast Cancer: Is This a Distinct Group? Am J Clin Pathol. 2014;141:697-701. PMID: 24713741.

• Faye F Gao, M.D., PhD., David J. Dabbs, M.D., Kristine L Cooper, M.S. and Rohit Bhargava, M.D. Bright-field HER2 dual in situ hybridization (DISH) assay versus fluorescence in situ hybridization (FISH): Focused study of immunohistochemical 2+ cases. Am J Clin Pathol. 2014;141:102-110. PMID: 24343743.

• Ashlee L. Smith, Mai Sun, Rohit Bhargava, Nicolas A. Stewart, Melanie S. Flint, William L. Bigbee, Thomas C. Krivak, Mary A. Strange, Kristine L. Cooper, Kristin K. Zorn. Proteomic analysis of matched formalin-fixed, paraffin-embedded specimens in patients with advanced serous ovarian carcinoma. Proteomes. 2013;1(3):240-253. Open access: http://www.mdpi.com/2227-7382/1/3/240

• Xin Li, Amal Kanbour-Shakir, David J Dabbs, Rohit Bhargava. Morphologic features do not influence response to trastuzumab containing neoadjuvant chemotherapy in HER2-positive breast cancer. Appl Immunohistochem Mol Morphol. 2013;21:420-425. PMID: 23165332.

• Hahm ER, Lee J, Kim SH, Sehrawat A, Arlotti JA, Shiva SS, Bhargava R, Singh SV. Metabolic Alteration in Mammary Cancer Prevention by Withaferin A in a Clinically Relevant Mouse Model. J Natl Cancer Inst. 2013;105:1111-1122. PMID: 23821767.

• Rohit Bhargava and David J Dabbs. Cancer of unknown primary origin: Using ancillary techniques with caution. J Clin Oncol. 2013;31(11):1478-9. PMID: 23439751.

http://www.mdpi.com/2227-7382/1/3/240

• Faye F Gao, MD, PhD, Rohit Bhargava, MD, Haitao Yang, MD, PhD, Zaibo Li, MD, PhD and Chengquan Zhao, MD. A Clinicopathological Study of Serous Tubal Intraepithelial Carcinoma with Invasive Carcinoma: Is Serous Tubal Intraepithelial Carcinoma a Reliable Feature to Determine Organ of Origin? Hum Pathol. 2013;44(8):1534-43. PMID: 23465279.

• Beth Z Clark, Kristi Cooper, David J Dabbs, Rohit Bhargava. Impact of Progesterone Receptor Semiquantitative Immunohistochemical Result on Oncotype DX® Recurrence Score: A Quality Assurance Study of 1074 Cases. Accepted to be published in Appl Immunohistochem Mol Morphol. 2013;21:287-291. PMID: 23060300.

• Molly E Klein, David J Dabbs, Yongli Shuai, Adam M Brufsky, Rachel Jankowitz, Shannon L Puhalla, Rohit Bhargava. Prediction of the Oncotype DX® Recurrence Score: Use of Pathology Generated Equations Derived by Linear Regression Analysis. Mod Pathol. 2013;26:658-664. PMID: 23503643.

• Jing Yu MD PhD, Sara E. Monaco MD, Rohit Bhargava MD, David J. Dabbs MD, Kathleen M. Cieply BS, Jeff L. Fine MD. A Validation Study of Quantum Dot Multispectral Imaging to Evaluate Hormone Receptor Status in Ductal Carcinoma In Situ (DCIS) of the Breast. Hum Pathol. 2013;44:394-401. PMID: 23039940.

• Beth Z Clark, and Rohit Bhargava. Bright Field Microscopy for HER2 Gene Assessment-Not Just DISH-ful Thinking? Am J Clin Pathol. 2013;139:137-139. PMID: 23355196.

• Mirka Jones, Agnieszka Onisko, David J Dabbs, Esther Elishaev, Simion I Chiosea, Rohit Bhargava. Immunohistochemistry and HPV in situ hybridization in distinction between endocervical and endometrial adenocarcinoma: A comparative tissue microarray study of 76 tumors. Int J Gynecol Cancer. 2013;23:380-384. PMID: 23318908.

• Rohit Bhargava, M.D., Adam M. Brufsky, M.D., PhD., Nancy E. Davidson, M.D. Prognostic/Predictive Immunohistochemistry Assays for Estrogen Receptor-Positive Breast Cancer: Back to the Future? J Clin Oncol. 2012;30:4451-4453. PMID: 23045595.

• Cohen DA, Dabbs DJ, Cooper KL, Amin M, Jones TE, Jones MW, Chivukula M, Trucco GA, Bhargava R. Inter-observer Agreement among Pathologists for Semi-Quantitative Hormone Receptor Scoring in Breast Carcinoma. Am J Clin Pathol. 2012;138:796-802. PMID: 23161712.

• Cancer Genome Atlas Network (Rohit Bhargava, one of 357 collaborators). Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61-70. PMID: 23000897.

• Nidhi Agarwal, Rohit Bhargava, Esther Elishaev. Diagnostic Use of Ki-67 Proliferation Marker As An Adjunct To Morphologic Diagnosis. Int J of Gyn Pathol. 2012;31:447-452. PMID: 22833085.

• Rohit Bhargava and David J Dabbs. Reply to M Christgen et al. J Clin Oncol. 2012;30:3314-3315. WebID: http://jco.ascopubs.org/content/30/26/3314.full

• Rajan K. Bista, Pin Wang, Rohit Bhargava, Shikhar Uttam, Douglas J. Hartman, Randall E. Brand, and Yang Liu. Nuclear nano-morphology markers of histologically normal cells detect the "field effect" of breast cancer. Breast Cancer Research and Treatment. 2012;135:115-124. PMID: 22706633.

• Isil Z Yildiz-Aktas, David J Dabbs, and Rohit Bhargava. The Effect of Cold Ischemic Time on the Immunohistochemical Evaluation of Estrogen Receptor, Progesterone Receptor, and HER2 Expression in Invasive Breast Carcinoma. Mod Pathol. 2012;25:1098-1105. PMID: 22460807.

• James A Kraus, David J Dabbs, Sushil Beriwal, and Rohit Bhargava. Semi-quantitative Immunohistochemical Assay versus Oncotype DX® qRT-PCR Assay for Estrogen and Progesterone Receptors: An Independent Quality Assurance Study. Mod Pathol. 2012;25:869-876. PMID: 22301704.

• James A. Kraus, Sushil Beriwal, David J. Dabbs, Gretchen M Ahrendt Kandace P McGuire, Ronald R Johnson, Preeti Badve, Shannon L Puhalla, and Rohit Bhargava. Predictors of Pathologic Complete Response after Standard Neoadjuvant Chemotherapy in Triple-negative Breast Carcinoma. Appl Immunohistochem Mol Morphol. 2012;20:334-339. PMID: 22417856.

• Isil Z Yildiz-Aktas, David J Dabbs, Kristine L Cooper, Mamatha Chivukula, Kim McManus, and Rohit Bhargava. The Effect of 96-Hour Formalin Fixation on the Immunohistochemical Evaluation of Estrogen Receptor, Progesterone Receptor, and HER2 Expression in Invasive Breast Carcinoma. Am J Clin Pathol. 2012;137:691-698. PMID: 22523206.

• Rohit Bhargava, Raymond R. Tubbs, Syed K Mohsin, David J Dabbs. Reply to A.M. Gown et al and F.L. Baehner et al. J Clin Oncol. 2012;30:1728-1729. PMID: 22493420.

• Rohit Bhargava and David J Dabbs. Oncotype DX® test on unequivocally HER2 positive cases: Potential for harm. J Clin Oncol. 2012;30:570-571. PMID: 22231308

• David J. Dabbs, Molly Klein, Syed Mohsin, Raymond R. Tubbs, and Rohit Bhargava. High false-negative rate of HER2 qRT-PCR of the Oncotype DX® test: An independent quality assurance study. J Clin Oncol. 2011;29:4279-4285. PMID: 21990395.

• Bhargava R, Sahoo S, Esposito NN, Chen B. Pathology of breast carcinoma: diagnostic, prognostic, and therapeutic issues and challenges. Patholog Res Int. 2011;2011:73140. PMID: 21961079.

• Kandace P. McGuire, MD, Jorge Toro-Burguete, MD, Hang Dang, DO, Jessica Young, MD, Atilla Soran, MD, MPH, Margarita Zuley, MD, Rohit Bhargava, MD, Marguerite Bonaventura, MD, Ronald Johnson, MD, Gretchen Ahrendt, MD. MRI staging after neoadjuvant chemotherapy for breast cancer: Does tumor biology affect accuracy? Ann Surg Oncol. 2011;18:3149-3154. PMID: 21947592.

• Anna H Woodard M.D., Jing Yu M.D., David J Dabbs M.D., Sushil Beriwal M.D., Anca V Florea M.D., Esther Elishaev, M.D., Jon M Davison M.D., Alyssa M Krasinskas M.D., and Rohit Bhargava M.D. NY-BR-1 and PAX8 immunoreactivity in breast, gynecologic tract and other CK7 positive carcinomas: Potential use for determining site of origin. Am J Clin Pathol. 2011;136:428-435. PMID: 21846919.

• Vargo JA, Beriwal S, Ahrendt GM, Soran A, Johnson RR, McGuire K, Bhargava R. Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer. Oncology 2011;80:341-349. PMID: 21791944. http://content.karger.com/ProdukteDB/produkte.aspDOI=10.1159/000330203

http://content.karger.com/ProdukteDB/produkte.aspDOI=10.1159/000330203

• Jing Yu, MD, PhD, David J. Dabbs, MD, Yongli Shuai, MS, Leo A. Niemeier, MD, Rohit Bhargava, MD. Classical Type Invasive Lobular Carcinoma with HER2 Overexpression: Clinical, Histological and Hormone Receptor Characteristics. Am J Clin Pathol. 2011 Jul;136(1):88-97. PMID: 21685036.

• Rohit Bhargava, M.D., Nicole N. Esposito, M.D., David J. Dabbs, M.D. Intracystic papillary carcinomas of the breast are more similar to in-situ carcinomas than invasive carcinoma. Am J Surg Pathol. 2011;35:778-779. PMID: 21451361.

• Rohit Bhargava M.D., Sushil Beriwal, M.D., Kim McManus, HT (ASCP), David J Dabbs, M.D. Insulin-Like Growth Factor Receptor-1 (IGF-1R) Expression In Normal Breast, Proliferative Breast Lesions And Breast Carcinoma. Appl Immunohistochem Mol Morphol. 2011;19:218-225. PMID: 21217522.

• Rohit Bhargava, M.D., David J. Dabbs, M.D., Sushil Beriwal, M.D., Isil A. Yildiz, M.D., Preeti Badve, Atilla Soran, M.D., Ronald R. Johnson, M.D., Adam M. Brufsky, M.D., Barry C. Lembersky, M.D., Kandace McGuire, M.D., and Gretchen M. Ahrendt, M.D. Semiquantitative hormone receptor level influences response to trastuzumab containing neoadjuvant chemotherapy in HER2 positive breast cancer. Mod Pathol. 2011;24:367-374. PMID: 21102420.

• Bateman, Nicholas; Sun, Mai; Bhargava, Rohit; Hood, Brian; Darfler, Marlene; Kovatich, Albert; Hooke, Jeffrey; Krizman, David; Conrads, Thomas. Differential Proteomic Analysis of Late-Stage and Recurrent Breast Cancer from Formalin-Fixed Paraffin-Embedded Tissues. J Proteome Res. 2011;10:1323-1332. PMID: 21155598.

• Amy S Gardiner, William C McBee, Jr., Robert P Edwards, Marshall Austin, Jamie L Lesnock, Rohit Bhargava, Richard Guido, and Saleem A Khan. MicroRNA analysis in human papillomavirus (HPV)-associated cervical neoplasia and cancer. Infectious Agents and Cancer 2010 5(Suppl 1):A55. PMCID: PMC3002716.

• Vera S. Donnenberg, Ph.D., Albert D. Donnenberg, Ph.D. Ludovic Zimmerlin, Rodney J. Landreneau, M.D., Rohit Bhargava, M.D., Ryan A. Wetzel, Per Basse, and Adam M. Brufsky, M.D. Localization of CD44 and CD90 positive cells to the invasive front of breast tumors. Cytometry B Clin Cytom. 2010 Sep;78(5):287-301. PMID: 20533389.

• David J Dabbs, M.D. and Rohit Bhargava, M.D. Letter Regarding Ibarra et al article titled “Fixation time does not affect the expression of estrogen receptor (Am J Clin Pathol. 2010; 133:747-755)”. Am J Clin Pathol. 2011 Jan;135(1):171-2. PMID: 21173141.

• Wang P, Bista R, Bhargava R, Brand RE, Liu Y. Spatial-domain low-coherence quantitative phase microscopy for cancer diagnosis. Opt Lett. 2010; 35(17):2840-2842. PMID: 20808342.

• Stergios Moschos, Drazen M. Jukic, Charalambos Athanassiou, Rohit Bhargava, Shih-Fan Kuan, Sanja Dacic, Shelley L. Fayewicz, Marie Acquafondata, Rajiv Dhir. Expression Analysis of Ubc9, the Single SUMO E2 Conjugating Enzyme, in Normal and Malignant Tissues. Hum Pathol. 2010;41:1286-98. PMID: 20561671.

• Jing Yu, Rohit Bhargava and David J Dabbs. Invasive lobular carcinoma with extracellular mucin production and HER-2 overexpression: a case report and further case studies. Diagnostic Pathology. 2010;5:36. PMID: 20550696.

• Teng, Pang-ning; Rungruang, Bunja; Hood, Brian; Sun, Mai; Flint, Melanie; Bateman, Nicholas; Dhir, Rajiv; Bhargava, Rohit; Richard, Scott; Edwards, Robert; Conrads, Thomas. Assessment of Buffer Systems for Harvesting Proteins from Tissue Interstitial Fluid for Proteomic Analysis. Journal of Proteome Research. 2010;9:4161-4169. PMID: 20518575.

• Dana Gingell, Amber Samuel, Denise Haynik, William McBee, Joseph Kelley, Kristen Zorn, Rohit Bhargava. Metastatic Ovarian Serous Carcinoma Presenting as Inflammatory Breast Cancer: A Case Report. Int J Gynecol Pathol. 2010;29:243-247. PMID: 20407323.

• Siobhan O’Connor, David J Dabbs, Sushil Beriwal, Rohit Bhargava. Concordance Between Semiquantitative Immunohistochemical Assay and Oncotype DX RT-PCR Assay for Estrogen and Progesterone Receptors. Appl. Immunohistochem Mol Morphol. 2010;18:268-272. PMID: 20186046.

• Rohit Bhargava, M.D., Sushil Beriwal, M.D., David J. Dabbs, M.D., Umut Ozbek, M.S., Atilla Soran, M.D., Ronald R. Johnson, M.D., Adam M. Brufsky, M.D., Barry C. Lembersky, M.D., Gretchen M. Ahrendt, M.D. Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy: A single institutional experience with 359 cases. Cancer. 2010;116:1431-1439. PMID: 20131351.

• Leo A. Niemeier, David J Dabbs, Sushil Beriwal, Joan Striebel, Rohit Bhargava. Androgen Receptor in Breast Cancer: Expression in Estrogen Receptor Positive Tumors and in Estrogen Receptor Negative Tumors with Apocrine Differentiation. Mod Pathol. 2010;23:205-212. PMID: 19898421.

• Rohit Bhargava, Sushil Beriwal, Joan Striebel, David J Dabbs. Breast Cancer Molecular Class ERBB2: Preponderance Of Tumors With Apocrine Differentiation And Expression Of Basal Phenotype Markers CK5, CK5/6 And EGFR. Appl Immunohistochem Mol Morphol. 2010;18:113-118. PMID: 19801938.

• Olga L. Bohn, Irem Nasir, Adam Brufsky, George C Tseng, Rohit Bhargava, Kim McManus, Mamatha Chivukula. Biomarker profile in breast carcinomas presenting with bone metastasis. Int J Clin Exp Pathol 2010;3(2):139-146. PMID: 20126581.

• Cagatay Ersahin, Mamatha Chivukula, Rohit Bhargava, David J Dabbs. Basal-like Subtype Breast Cancers in Women Older than 40 Years of Age. Int J Surg Pathol. 2010;18:42-47. PMID: 19372082.

• Sushil Beriwal, Bunja Rungruang, Atilla Soran, Darcy Thull, Joseph L Kelley, Rohit Bhargava, Chyongchiou J. Lin, Paniti Sukumvanich. Comparison of Locoregional Recurrence with Mastectomy vs. Breast Conserving Surgery in Pregnancy Associated Breast Cancer (PABC). Cancers. 2009, 1(1), 12-20; doi:10.3390/cancers1010012. PMID:

• Hughes SJ, Xi, L, Gooding WE, Cole DJ, Mitas M, Metcalf J, Bhargava R, Dabbs D, Ching J, Kozma L, McMillan W, Godfrey TE. A Quantitative Reverse Transcription-PCR Assay for Rapid Automated Analyses of Breast Cancer Sentinel Lymph Nodes. J Mol. Diagn. 2009;11:576-582. PMID: 19797614.

• Mamatha Chivukula, David J Dabbs, Siobhan O’Connor, Rohit Bhargava.PAX2: a novel müllerian marker for serous papillary carcinomas to differentiate from micropapillary breast carcinoma. Int J Gynecol Pathol. 2009;28:570-578. PMID: 19851209.

http://dx.doi.org/10.3390/cancers1010012

• Cagatay Ersahin, Sudeshna Bandyopadhyay, and Rohit Bhargava. Thyroid transcription factor-1 and “basal-marker” expressing small cell carcinoma of the breast. Int J Surg Pathol. 2009;17:368-372.

• Mamatha Chivukula, Rohit Bhargava, David J Dabbs. Clinicopathologic Implications of ‘Flat Epithelial Atypia’ on Core Needle Biopsies of Breast. Am J Clin Pathol. 2009;131:802-808.

• Bulent Unal, A Serhat Gur, Rohit Bhargava, Howard Edington, Gretchen Ahrendt, Atilla Soran. Bratisl Lek Listy. Intraductal location of the sclerosing adenosis of the breast. 2009;11(4):251-252.

• Rohit Bhargava, Joan Striebel, Sushil Beriwal, John C. Flickinger, Agnieszka Onisko, Gretchen Ahrendt and David J. Dabbs. Prevalence, Morphologic Features and Proliferation Indices of Breast Carcinoma Molecular Classes Using Immunohistochemical Surrogate Markers. Int J Clin Exp Pathol 2009;2(5):444-455.

• Nicole N Esposito, David J Dabbs, Rohit Bhargava. Are encapsulated papillary carcinomas of the breast in-situ or invasive? A basement membrane study of 27 cases. Am J Clin Pathol. 2009;131:228-242. PMID: 19141383.

• Rohit Bhargava, M.D. Sushil Beriwal, M.D. Kim McManus, M.D. David J Dabbs, M.D. CK5 is more sensitive than CK5/6 in identifying “basal-like” phenotype of breast carcinoma. Am J Clin Pathol. 2008;130:724-730.

• Rohit Bharagva and David J Dabbs. Luminal B tumors are not HER2 positive. Breast Cancer Research. 2008;10:404.

• Rohit Bhargava, M.D., Mamatha Chivukula, M.D., Sushil Beriwal, David J. Dabbs, M.D. Estrogen and Progesterone Receptors in Breast Carcinoma: Quantitation is Therapeutically Important. Adv Anat Pathol. 2008 Sep;15(5):304-305.

• Mamatha Chivukula, M.D., Rohit Bhargava, M.D., David J. Dabbs, M.D. Diagnostic, Theranostic and Genomic Immunohistochemistry: Standardization Issues. Adv Anat Pathol. 2008 Sep;15(5):302-304.

• Kazuya Onuma, David J Dabbs, Rohit Bhargava. Mammaglobin Expression In The Female Genital Tract: Immunohistochemical Analysis in Benign and Neoplastic Endocervix and Endometrium. Int J of Gynecol Pathol. 2008;27:418-425.

• Akosua B Domfeh, AnnaMarie L Carley, Joan M Striebel, Rouzan G Karabakhtsian, Anca V Florea, Kim McManus, Sushil Beriwal and Rohit Bhargava. WT-1 immunoreactivity in breast carcinoma: Selective expression in pure and mixed mucinous subtypes. Mod Pathol. 2008;21:1217-1223.

• Melina B. Flanagan, MD, MSPH, David J. Dabbs, MD, Adam Brufsky, MD, PhD, Sushil Beriwal, MD, Rohit Bhargava, MD. Histopathologic Variables Predict Oncotype DX™ Recurrence Score. Mod Pathol. 2008;21:1255-1261.

• Chivukula M, Bhargava R, Brufsky A, Surti U, Dabbs DJ. Clinical importance of HER2 immunohistologic heterogenous expression in core-needle biopsies vs resection specimens for equivocal (immunohistochemical score 2+) cases. Mod Pathol. 2008;21:363-368.

• Joan M. Striebel, Rohit Bhargava, Craig Horbinski, Urvashi Surti, David J. Dabbs. The Equivocally Amplified HER2 FISH Result on Breast Core Biopsy: Indications for Further Sampling Do Affect Patient Management. Am J Clin Pathol. 2008;129:383-390.

• David Coon, Sushil Beriwal, Steven H. Swerdlow, Rohit Bhargava. Mucosa-Associated Lymphoid Tissue Lymphoma of the Cervix. J Clin Oncol. 2008;26(3):503-504.

• Lu Wang, Rohit Bhargava, Tao Zheng, Leonard Wexler, Margaret Collins, Diane Roulston, Marc Ladanyi (LW and RB contributed equally). Undifferentiated Small Round Cell Sarcomas with Rare EWS Gene Fusions: Identification of a Novel EWS-SP3 Fusion and of Additional Cases with the EWS-ETV1 and EWS-FEV Fusions. J Mol Diagn 2007;9:498-509.

• Pasquali L, Bedeir A, Ringquist S, Styche A, Bhargava R, Trucco G. Quantification of CpG island methylation in progressive breast lesions from normal to invasive carcinoma. Cancer Lett. 2007;257(1):136-144.

• David J Dabbs, M.D., Rohit Bhargava, M.D., Mamatha Chivukula, M.D. Lobular versus ductal breast neoplasms: The diagnostic utility of p120 catenin in the breast and in metastatic tumors. Am J Surg Pathol. 2007 Mar;31(3):427-437.

• Rohit Bhargava, M.D. and David J. Dabbs, M.D.Use of Immunohistochemistry in the diagnosis of breast epithelial lesions. Adv Anat Pathol. 2007;14:93-107.

• Rohit Bhargava M.D., Sushil Beriwal M.D., David J Dabbs M.D. Mammaglobin Versus GCDFP-15: An Immunohistologic Validation Survey For Sensitivity And Specificity. Am J of Clin Pathol. 2007 Jan;127(1):103-113.

• Dabbs DJ, Chivukula M, Carter G, Bhargava R. Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile. Mod Pathol. 2006 Nov;19(11):1506-11.

• Rohit Bhargava, M.D., Beiyun Chen, M.D., Ph.D., David S. Klimstra, M.D., Leonard B. Saltz, M.D., Cyrus Hedvat, M.D., Ph.D., Laura, Tang, M.D., PhD., William Gerald, M.D., PhD., Julie Teruya-Feldstein, M.D., Philip B. Paty, M.D., Jing Qin, Ph.D., Jinru Shia, M.D. Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa. Cancer. 2006 Apr 15;106(8):1857-62.

• Bhargava R, Gerald WL, Li AR, Pan Q, Lal P, Ladanyi M, Chen B. EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations. Mod Pathol. 2005 Aug;18(8):1027-33.

• Bhargava R, Oppenheimer O, Gerald W, Jhanwar SC, Chen B. Identification of MYCN gene amplification in neuroblastoma using chromogenic in situ hybridization (CISH): an alternative and practical method. Diagn Mol Pathol. 2005 Jun;14(2):72-6.

• Bhargava R, Lal P, Chen B. HER-2/neu and Topoisomerase IIa Gene Amplification and Protein Expression in Invasive Breast Carcinomas: Chromogenic In Situ Hybridization and Immunohistochemical Analyses. Am J Clin Pathol. 2005 Jun;123(6):889-95.

• Rohit Bhargava, Priti Lal, Beiyun Chen. Chromogenic in situ hybridization for the detection of HER-2 gene amplification in breast cancer with an emphasis on tumors with borderline and low-level amplification. Does it measure up to fluorescence in situ hybridization? Am J Clin Pathol. 2005;123:237-243.

• Bhargava R, Shia J, Hummer AJ, Thaler HT, Tornos C, Soslow RA. Distinction of endometrial stromal sarcomas from “hemangiopericytomatous” tumors using a panel of commonly used immunohistochemical stains. Mod Pathol. 2005 Jan;18(1):40-7.

• Darvishian, Farbod MD; Hummer, Amanda J. MS; Thaler, Howard T. PhD; Bhargava, Rohit MBBS; Linkov, Irina BS; Asher, Marina BS; Soslow, Robert A. MD. Serous Endometrial Cancers That Mimic Endometrioid Adenocarcinomas: A Clinicopathologic and Immunohistochemical Study of a Group of Problematic Cases. Am J Surg Pathol. 2004;28:1568-78.

• Rohit Bhargava, Priti Lal, Beiyun Chen. Feasibility of Using Tissue Microarrays for the Assessment of HER-2 Gene Amplification by Fluorescence In Situ Hybridization in Breast Carcinoma. Diagn Mol Pathol. 2004 Dec;13(4):213-6.

• Rohit Bhargava, Violetta Barbashina, Daniel A. Filippa and Julie Teruya-Feldstein. Epstein-Barr Virus Positive Large B-Cell Lymphoma Arising in a Patient Previously Treated with Cladribine for Hairy Cell Leukemia. Leuk Lymphoma. 2004;45(5):1043-1048.

• Rohit Bhargava, Rizwan Naeem, Sharon Marconi, Jason Luszcz, Jane Garb, Robert Gasparini and Christopher N Otis. Tyrosine Kinase Activation in Breast Carcinoma With Correlation to HER-2/neu Gene Amplification and Overexpression. Hum Pathol. 2001;32:1344-50.

• Sanjay Dhar, Rohit Bhargava, Michael Yunes, Biao Li, Jaya Goyal, Stephen P Naber, David E Wazer and Vimla Band. Analysis of Normal Epithelial Cell Specific-1 (NES1)/Kallikrein 10 mRNA Expression by in Situ Hybridization, a novel marker for breast cancer. Clin Cancer Res. 2001;7:3393-8.

Refereed Articles (Accepted for publication)

• Pareja F, da Silva EM, Frosina D, Geyer FC, Lozada JR, Basili T, Da Cruz Paula A, Zhong E, Derakhshan F, D'Alfonso T, Wen HY, Giri DD, Hayes MM, Krings G, Bhargava R, Palazzo JP, Rakha EA, Hoda SA, Sanders ME, Collins LC, Schnitt SJ, Chen YY, Weigelt B, Jungbluth AA, Reis-Filho JS, Brogi E. Immunohistochemical Analysis of IDH2 R172 Hotspot Mutations in Breast Papillary Neoplasms: Applications in the Diagnosis of Tall Cell Carcinoma with Reversed Polarity. Accepted to be published in Mod Pathol. PMID: 31896809.

• Jones TE, Pradhan D, Dabbs DJ, Bhargava R, Onisko A, Jones MW. Immunohistochemical markers with potential diagnostic, prognostic, and therapeutic significance in uterine carcinosarcoma: a clinicopathologic study of 43 cases. Accepted to be published in Int J Gyn Pathol. PMID: 31855950.

Other Publications

• Rohit Bhargava, M.D. Epidermal Growth Factor Receptor in Breast Carcinoma: An Overview. Dako Connections Scientific Magazine. 2009;13:40-43. http://pri.dako.com/connection_13_july09_final_low_res.pdf

Book

• Simplified and Illustrated Breast Pathology: A Book for All Breast Care Providers. Sole author: Rohit Bhargava. Published by Jaypee Brothers Medical Publishers. May 2015.

Book Chapters

• Approach to histopathologic diagnosis. Rohit Bhargava, M.D. and Wendie Berg, M.D. Diagnostic Imaging: Breast, 3rd Edition (Berg W, Leung JWT Ed), Elsevier, USA.

• Immunohistology of the Breast. Rohit Bhargava, M.D. (first author), and David J Dabbs, M.D. Diagnostic Immunohistochemistry: Theranostic and Genomic Applications, 5th edition (Dabbs DJ, Ed), Elsevier, USA. February 2018.

• Immunohistology of Carcinoma of Unknown Primary Site. Rohit Bhargava, M.D. (first author) and David J Dabbs, M.D. Diagnostic Immunohistochemistry: Theranostic and Genomic Applications, 5th edition (Dabbs DJ, Ed), Elsevier, USA. February 2018.

• Apocrine Carcinoma. Rohit Bhargava, M.D. Textbook of Breast Pathology, 2nd edition (Dabbs DJ, Ed), Elsevier, USA. November 4, 2016.

• Molecular classification of breast carcinomas. Rohit Bhargava, M.D. Textbook of Breast Pathology, 2nd edition (Dabbs DJ, Ed), Elsevier, USA. November 4, 2016.

• Immunohistology of the Breast. Rohit Bhargava, M.D. and David J Dabbs, M.D. Textbook of Breast Pathology, 2nd edition (Dabbs DJ, Ed), Elsevier, USA. November 4, 2016.

• Pathology of neoadjuvant therapeutic response of breast carcinoma. Sunati Sahoo, M.D., David J Dabbs, M.D., and Rohit Bhargava, M.D. Textbook of Breast Pathology, 2nd edition (Dabbs DJ, Ed), Elsevier, USA. November 4, 2016.

• Predictive and prognostic marker testing in breast pathology: immunophenotypic subclasses of disease. Rohit Bhargava, M.D. and David J Dabbs, M.D. Textbook of Breast Pathology, 2nd edition (Dabbs DJ, Ed), Elsevier, USA. November 4, 2016.

• Immunohistology of the Breast. Rohit Bhargava, M.D. (first author), and David J Dabbs, M.D. Diagnostic Immunohistochemistry: Theranostic and Genomic Applications, 4th edition (Dabbs DJ, Ed), Elsevier, USA. December 2013.

• Immunohistology of Metastatic Carcinomas of Unknown Primary. Rohit Bhargava, M.D. (first author) and David J Dabbs, M.D. Diagnostic Immunohistochemistry: Theranostic and Genomic Applications, 4th edition (Dabbs DJ, Ed), Elsevier, USA. December 2013.

• Approach to histopathologic diagnosis. Rohit Bhargava, M.D. and Wendie Berg, M.D. Diagnostic Imaging: Breast, 2nd Edition (Berg W, Yang W Ed), Amirsys, USA. November 2013

• Apocrine Carcinoma. Rohit Bhargava, M.D. Textbook of Breast Pathology (Dabbs DJ, Ed), Elsevier, USA. February 2012.

• Molecular classification of breast carcinomas. Rohit Bhargava, M.D. Textbook of Breast Pathology (Dabbs DJ, Ed), Elsevier, USA. February 2012.

• Immunohistology of the Breast. Rohit Bhargava, M.D. and David J Dabbs, M.D. Textbook of Breast Pathology (Dabbs DJ, Ed), Elsevier, USA. February 2012.

• Pathology of neoadjuvant therapeutic response of breast carcinoma. Sunati Sahoo, M.D., Rohit Bhargava, M.D. and David J Dabbs, M.D. Textbook of Breast Pathology (Dabbs DJ, Ed), Elsevier, USA. February 2012.

• Predictive and prognostic marker testing in breast pathology: immunophenotypic subclasses of disease. D Craig Allred, M.D., Rohit Bhargava, M.D. and David J Dabbs, M.D. Textbook of Breast Pathology (Dabbs DJ, Ed), Elsevier, USA. February 2012.

• Immunohistology of the Breast. Rohit Bhargava, M.D. (first author), Nicole N Esposito, M.D., David J Dabbs, M.D. Diagnostic Immunohistochemistry: Theranostic and Genomic Applications, 3rd edition (Dabbs DJ, Ed), Elsevier, USA. February 2010.

• Immunohistology of Metastatic Carcinomas of Unknown Primary. Rohit Bhargava, M.D. (first author) and David J Dabbs, M.D. Diagnostic Immunohistochemistry: Theranostic and Genomic Applications, 3rd edition (Dabbs DJ, Ed), Elsevier, USA. February 2010.

• Pathologic Evaluation of Metastases: Immunohistology. Rohit Bhargava, M.D. (first author), Mark R Wick, M.D., David J Dabbs, M.D. Metastatic Carcinomas of Unknown Origin (Wick MR, Ed), Demos Medical Publishing, New York, 2008.

Abstracts (Published)

• Rohit Bhargava, Beth Z Clark, Gloria J. Carter, Adam M Brufsky, David Dabbs. Magee Decision Algorithm: An Algorithmic Approach Using Magee Equations and Mitosis Score to Safely Forgo Molecular Testing in Breast Cancer. USCAP annual meeting, Los Angeles, CA. February 29-March 5, 2020.

• Tiannan Wang, Rohit Bhargava, Cheng Zhiqiang, Chengquan Zhao. A Five-Year Retrospective Clinicopathological Analysis of Vulvar Squamous Cell Carcinoma in a Large Tertiary Care Women’s Hospital. USCAP annual meeting, Los Angeles, CA. February 29-March 5, 2020.

• Sarah B Hugar, Rohit Bhargava, Beth Z Clark. Beta-Catenin: Use and Interpretation in the Differential Diagnosis of Fibromatosis of the Breast. USCAP annual meeting, Los Angeles, CA. February 29-March 5, 2020.

• Beth Z Clark, Ronald R. Johnson, Rohit Bhargava. Regional Lymph Node Status following Neoadjuvant Chemotherapy for Breast Carcinoma - Correlation with Breast Response and Accuracy of Radioactive Seed Localization. USCAP annual meeting, Los Angeles, CA. February 29-March 5, 2020.

• Rohit Bhargava, Nicole Nicosia Esposito, Siobhan M O'Connor, Zaibo Li, Bradley M. Turner, Ioana Moisini, Aditi C Ranade, Dylan V. Miller, Xiaoxian Li, Harrison Moosavi, Beth Z Clark, David Dabbs. Magee Equations™ and Response to Neoadjuvant

Chemotherapy in ER+/HER2-Negative Breast Cancer: A Multi-Institutional Validation Study. USCAP annual meeting, Los Angeles, CA. February 29-March 5, 2020.

• Swikrity U Baskota, Rohit Bhargava. Prognostic Value of Size, Node, and Ki-67 index (SiNK) in Breast Cancer. USCAP annual meeting, Los Angeles, CA. February 29-March 5, 2020.

• Terri E Jones, Somak Roy, Rohit Bhargava. The Utility of Next Generation Sequencing in Advanced Breast and Gynecologic Cancers: Experience of a Large Tertiary Care Women's Hospital. USCAP annual meeting, Los Angeles, CA. February 29-March 5, 2020.

• Terri E Jones, Hae-Sun La, Rohit Bhargava, Mirka W. Jones. The Potential Prognostic and Therapeutic Implications of Prolactin Receptor and Growth Hormone-Releasing Hormone Receptor Expression in Uterine Leiomyosarcomas. USCAP annual meeting, Los Angeles, CA. February 29-March 5, 2020.

• Rohit Bhargava, Beth Z. Clark, Gloria J. carter, David J. Dabbs. Magee decision algorithm™: a safe and effective method to make therapy decisions without oncotype dx® testing. San Antonio Breast Cancer Symposium. San Antonio, TX. December 10-14, 2019. Abstract # 160. Program Number: P3-07-03.

• Sarah B Hugar, Eric Statz, Mirka W Jones, Esther Elishaev, Rohit Bhargava. IFITM1 as an Endometrial Stromal Marker: Diagnostic Use in Determining Myoinvasion in Endometrial Carcinoma and Distinction of Stromal Lesions from Smooth Muscle Tumors. USCAP annual meeting, National Harbor, MD. March 16-21, 2019.

• Stephanie N David, Michelle Heayn, David Dabbs, Beth Clark, Rohit Bhargava. Mammaprint: Histo-Pathologic Associations and Comparison to Magee Equations. USCAP annual meeting, National Harbor, MD. March 16-21, 2019.

• Michelle Heayn, Li Zhu, Stephanie David, Esther Elishaev, Rohit Bhargava. Improved Prognostic Stratification of the Chemotherapy Response Score with Ki-67 Labeling Index: A Single Institution Study of 177 Tubo-Ovarian Carcinomas. USCAP annual meeting, National Harbor, MD. March 16-21, 2019.

• Breast cancers with Magee Equation score of less than 25 and mitosis score of 1 do not require oncotype DX® testing: A Value Study. Rohit Bhargava, Beth Clark, David J Dabbs. Platform Presentation. Mod Pathol. 2018;31(issue S2): Publication #. USCAP annual meeting, Vancouver, BC, Canada. March 17-22, 2018.

• Distribution of p53 and p16 immunohistochemical staining identifies different pathways of vulvar carcinogenesis. Dinesh Pradhan, Zachary Horne, Sushil Beriwal, Paniti Sukumvanich, Rohit Bhargava. Mod Pathol. 2018;31(issue S2): Publication #. USCAP annual meeting, Vancouver, BC, Canada. March 17-22, 2018.

• Mammary Myofibroblastoma: A Clinicopathologic study of 27 cases. Seema Jabbar, Kavita Varma, Beth Clark, Yisheng Fang, Rohit Bhargava, Sunati Sahoo. Mod Pathol. 2018;31(issue S2): Publication #. USCAP annual meeting, Vancouver, BC, Canada. March 17-22, 2018.

• The Health Care Value of Oncotype DX® for Patients with Recurrence Scores of 10 or Less: A Value Based Pathology Study of Tumor Biology with Outcomes. David J Dabbs, Beth Clark, Kate Serdy, Rohit Bhargava, Sherie Smalley, Stephen Perkins, Adam Brufsky.

Mod Pathol. 2018;31(issue S2): Publication #. USCAP annual meeting, Vancouver, BC, Canada. March 17-22, 2018.

• Pathologic Complete Response Rate and Clinical Outcome of Metaplastic Breast Carcinoma After Neoadjuvant Chemotherapy. Min Han, Huina Zhang, Beth Clark, David J Dabbs, Rohit Bhargava. Mod Pathol. 2018;31(issue S2): Publication #. USCAP annual meeting, Vancouver, BC, Canada. March 17-22, 2018.

• Xin Li, Jose Pablo Leone, Kate Serdy, Binara Assylbekova, Kavita Rakesh Varma, Beth Z Clark, David J Dabbs, Rohit Bhargava. Prognostic Significance of PD-1/PDL-1 Expression in Breast Cancer and Tumor Associated Immune Cells. Publication # 209. USCAP annual meeting, San Antonio, TX. March 4-10, 2017.

• Kavita Varma, Jing Yu, Binara Assylbekova, Xin Li, Esther Elishaev, Amal Kanbour-Shakir, Beth Z Clark, David J Dabbs, Rohit Bhargava. Clinical Utility of SATB2 in Determining Site of Origin in Abdomino-Pelvic Tumors. Publication # 1258. USCAP annual meeting, San Antonio, TX. March 4-10, 2017.

• Binara Assylbekova, Jose Pablo Leone, Kate Serdy, Xin Li, Kavita Rakesh Varma, Esther Elishaev, Beth Z Clark, David J Dabbs, Rohit Bhargava. Prognostic Significance of PD-1 and PDL-1 Expression in Ovarian Carcinomas and Tumor Associated Immune Cells. Publication # 1103. USCAP annual meeting, San Antonio, TX. March 4-10, 2017.

• Mirka W Jones, Dinesh Pradhan, Agnieszka Onisko, Rohit Bhargava, David J Dabbs. Expression of PD-L1 and GHRH-R in Uterine Carcinosarcoma: Potential Markers for Targeted Therapy. Publication # 1174. USCAP annual meeting, San Antonio, TX. March 4-10, 2017.

• Sarah B Hugar, Rohit Bhargava, David J Dabbs, Beth Z Clark. Flat Epithelial Atypia on Core Biopsy Is Not Associated with Upstage at Excision. Publication # 182. USCAP annual meeting, San Antonio, TX. March 4-10, 2017.

• David J Dabbs, Kate Serdy, Adam M Brufsky, Rohit Bhargava. Value and Clinical Utility of Oncotype Dx for Patients with Recurrence Scores of 10 or Less: An Independent Value Study of Tumor Histopathology and Outcomes. Publication # 140. USCAP annual meeting, San Antonio, TX. March 4-10, 2017.

• David J Dabbs, Agnieszka Onisko, Binara Assylbekova, Xin Li, Rohit Bhargava, Beth Z Clark. Breast Cancer Global Tumor Biomarkers: A Quality Assurance Study of Intratumor Heterogeneity. Publication # 141. USCAP annual meeting, San Antonio, TX. March 4-10, 2017.

• Daniel J. Farrugia, Alessandra Landmann, Emilia Diego, Priscilla F. McAuliffe, Ronald Johnson, Marguerite Bonaventura, Atilla Soran, Beth Z Clark, David J. Dabbs, Shannon Puhalla, Rachel Catherine Jankowitz, Adam Brufsky, Barry C. Lembersky, Nancy E. Davidson, Gretchen M. Ahrendt, Rohit Bhargava. Prognostic significance of a modified residual disease in breast and nodes (mRDBN) algorithm after neoadjuvant therapy for breast cancer. 2016 San Antonio Breast Cancer Symposium. P6-09-14. Abstract # 433.

• Alessandra Landmann, Daniel J. Farrugia, Emilia Diego, Marguerite Bonaventura, Atilla Soran, Ronald Johnson, David J. Dabbs, Beth Clark, Adam Brufsky, Nancy E. Davidson, Barry C. Lembersky, Rachel Catherine Jankowitz, Shannon Puhalla, Gretchen M. Ahrendt, Priscilla F. McAuliffe, Rohit Bhargava. HER2 equivocal breast cancer and

neoadjuvant therapy: Is response similar to HER2-positive or HER2-negative tumors? Publication # 612. 2016 ASCO annual meeting June 3-7, 2016.

• Alessandra Landmann, Daniel J. Farrugia, Emilia Diego, Atilla Soran, Ronald Johnson, Marguerite Bonaventura, David J. Dabbs, Beth Clark, Adam Brufsky, Nancy E. Davidson, Barry C. Lembersky, Rachel Catherine Jankowitz, Shannon Puhalla, Gretchen M. Ahrendt, Priscilla F. McAuliffe, Rohit Bhargava. Low estrogen receptor (ER) positive breast cancer and neoadjuvant systemic therapy (NAT): Is response similar to ER+ or to ER- disease? Publication # 580. 2016 ASCO annual meeting June 3-7, 2016.

• Daniel J. Farrugia, Alessandra Landmann, Emilia Diego, Priscilla F. McAuliffe, Ronald Johnson, Marguerite Bonaventura, Atilla Soran, David J. Dabbs, Shannon Puhalla, Rachel Catherine Jankowitz, Adam Brufsky, Barry C. Lembersky, Priya Rastogi, Nancy E. Davidson, Gretchen M. Ahrendt, Rohit Bhargava. Utilization of Magee equation 3 in ER-positive, HER2-negative/equivocal tumors to determine pathologic response to neoadjuvant therapy. Abstract # 11594. 2016 ASCO annual meeting June 3-7, 2016.

• Kate M Serdy, David Dabbs, Rohit Bhargava. Immunohistochemical Profile of Male Breast Carcinoma. Publication # 279. USCAP annual meeting, Seattle, WA. March 12-18, 2016.

• Catherine Stoos, Rohit Bhargava, Gloria J Carter, Abbie Mallon, David Dabbs. Quality Assurance Protocols for Breast and Gynecologic Pathology Practice in a CLIA Laboratory Minimize Serious Events and Maximize Patient Safety. Publication # 2010. USCAP annual meeting, Seattle, WA. March 12-18, 2016.

• Kate M Serdy, David Dabbs, Rohit Bhargava. Male Breast Cancers: Are They Different Than Female Breast Cancers? Publication # 278. USCAP annual meeting, Seattle, WA. March 12-18, 2016.

• Grzegorz T Gurda, Kate M Serdy, David Dabbs, Rachel Jankowitz, Shannon L Puhalla, Adam Brufsky, Rohit Bhargava. Molecular Alterations and Clinical Test Utilization in Advanced Breast Cancer - Parallel Characterization of Two Next-Generation Sequencing Panels. Publication # 166. USCAP annual meeting, Seattle, WA. March 12-18, 2016.

• Ioana Moisini, Rajiv Dhir, Aatur Singhi, Aditi Ranade, Esther Elishaev, David Dabbs, Rohit Bhargava. Uroplakin 2: A Specific Marker of Urothelial Carcinoma. Publication # 996. USCAP annual meeting, Seattle, WA. March 12-18, 2016.

• Catherine Stoos, Shannon Huggins-Puhalla, David Dabbs, Rohit Bhargava. Androgen Receptor Status and Prediction of Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer. Publication # 288. USCAP annual meeting, Seattle, WA. March 12-18, 2016.

• Michelle Stram, Dinesh Pradhan, David Dabbs, Rohit Bhargava, Agnieszka Onisko, Mirka W Jones. The Use of Immunohistochemistry in Distinction between Clear Cell and Squamous Differentiation in Adenocarcinoma of the Endometrium. Publication # 1238. USCAP annual meeting, Seattle, WA. March 12-18, 2016.

• Leone JP, Zwenger O, Iturbe J, Leone J, Leone BA, Vallejo CT, Bhargava R. Prognostic factors in male breast cancer: a population based study. 2015 San Antonio Breast Cancer Symposium. P6-19-01.

• Soran A, Johnson RR, Menekse E, Bhargava R, McAuliffe P, Ahrendt GM, Dabbs DJ, Bonaventura M. Prediction of response to neoadjuvant chemotherapy in ER+ breast cancer: Magee equation recurrence versus oncotype DX® recurrence score. 2015 San Antonio Breast Cancer Symposium. P5-02-05.

• Dabbs DJ, Cooper KL, Brufsky AM, Rosenzweig P, Bhargava R. Pathology data predicts MammaPrint result- The Magee MammaPrint equation. 2015 San Antonio Breast Cancer Symposium. P5-07-04.

• Tadeu Frantz Ambros, Grzegorz Gurda, Adrian V. Lee, Adam Brufsky, Steffi Oesterreich, Rohit Bhargava, Marina Nikiforova, Yuri Nikiforov, Shannon Puhalla. Next-generation sequencing in a cohort of metastatic breast cancer (MBC) patients. 2015 ASCO annual meeting. J Clin Oncol 33, 2015 (suppl; abstr e22053).

• Aatur Singhi, Rohit Bhargava, Miroslawa W Jones, Kristi L Cressman, Raja R Seethala. ATRX Loss Is a Poor Prognostic Factor in Extrauterine Leiomyosarcomas. Publication # 93. USCAP annual meeting, Boston, MA. March 21-27, 2015.

• Characterization of Molecular Alterations and Clinical Utilization of Targeted Next-Generation Sequencing in Advanced Breast Cancer. Grzegorz T Gurda, Tadeu Ambrose, Marina Nikiforova, Yuri E Nikiforov, David Dabbs, Shannon L Puhalla, Rohit Bhargava. Publication # 180. USCAP annual meeting, Boston, MA. March 21-27, 2015.

• Incidental Findings of Tubal Intraepithelial Neoplastic Changes in Women With Gynecologic Surgical Intervention for Non-Malignant Conditions. Esther Elishaev, and Rohit Bhargava. Publication # 1128. USCAP annual meeting, Boston, MA. March 21-27, 2015.

• Jennifer Leidy, Esther Elishaev, Aatur Singhi, Miroslawa W Jones, David Dabbs, Rohit Bhargava. Can CA IX Be Used To Distinguish Between Gynecologic, Pancreatic and Cholangiocarcinoma? A Tissue Microarray Study of 757 Tumors. Publication # 1178. USCAP annual meeting, Boston, MA. March 21-27, 2015.

• Jose P Leone, Rohit Bhargava, Adrian Lee, Adam Brufsky. Expression of high affinity folate receptor in breast cancer brain metastasis. 2014 San Antonio Breast Cancer Symposium. Publication Number: P6-01-15.

• Zaibo Li, David J. Dabbs and Rohit Bhagava. Dual ERBB2 (HER2) Gene Protein Assay: Focused Study of Breast Cancers with 2+ Immunohistochemical Expression. Publication # 247. USCAP annual meeting, San Diego, CA. March 1-7, 2014.

• Zaibo Li, Aditi Ranade, Daman Samrao, Jeffrey Fine, David J. Dabbs and Rohit Bhagava. Interobserver agreement for HER2 gene amplification on Simultaneous Gene Protein Assay in Breast Cancer. Publication # 2147. USCAP annual meeting, San Diego, CA. March 1-7, 2014.

• Zaibo Li, Rohit Bhargava, Kevin Staton, Hong Wang, Shikhar Uttam, Randall E. Brand, Atilla Soran,Gretchen M. Ahrendt and Yang Liu. Nuclear Nano-morphology Markers Predict Breast Cancer Risk in Patients with Atypical Breast Epithelial Hyperplasia. Publication # 248. USCAP annual meeting, San Diego, CA. March 1-7, 2014.

• Daman Samrao, Rohit Bhargava, David J Dabbs, Beth Z Clark. Comparative Study of Ki67 Labeling Index in HER2 Amplified Versus Non-Amplified Estrogen Receptor Positive

Invasive Carcinoma of the Breast. Publication # 308. USCAP annual meeting, San Diego, CA. March 1-7, 2014.

• Daman Samrao, Aditi Ranade, Esther Elishaev, Rohit Bhargava. Folate Receptor Alpha Expression in Gynecologic Tumors. Publication # 1256. USCAP annual meeting, San Diego, CA. March 1-7, 2014.

• Beth Z Clark, Surabhi Beriwal, David J Dabbs, Rohit Bhargava. Clinical utility of GATA-3 expression in cytokeratin-7 positive carcinomas. Publication # 157. USCAP annual meeting, San Diego, CA. March 1-7, 2014.

• Amal Kanbour-Shakir, Esther Elishaev, Beth Dudley, Dima Al-Hamdawi, Marilyn Huang, David J Dabbs, Rohit Bhargava. Universal Mismatch Repair Protein Testing in Endometrial Cancer: A Single Institutional Experience. Publication # 1194. USCAP annual meeting, San Diego, CA. March 1-7, 2014.

• Treatment decisions and five year outcomes of the oncotype Dx test: An independent assessment. Bhargava R, Brufsky AM, Lembersky BC, Jankovic R, Puhalla SL, Oesterreich S, Lee A, Dabbs DJ. 2013 San Antonio Breast Cancer Symposium. December 10-14, 2013. Program # P6-06-46.

• HER2 copy number on FISH as a predictor of disease severity in HER2- breast cancer. Abedin S, Kruse M, Brufsky A, Bhargava R. 2013 San Antonio Breast Cancer Symposium. December 10-14, 2013. Program # P3-05-02.

• Intra-tumor heterogeneity affects multi-gene test prognostic risk stratification. Lee AV, Lin Y, Lin H-M, Cooper KL, Normolle DP, Brufsy AM, Fastuca M, Crosson W, Oesterreich S, Davidson NE, Bhargava R, Dabbs DJ. 2013 San Antonio Breast Cancer Symposium. December 10-14, 2013. Program # P2-11-10.

• Clinical utility of combined brightfield HER2 gene-protein assay in IHC equivocal cases. Bhargava R, Dabbs DJ. 2013 San Antonio Breast Cancer Symposium. December 10-14, 2013. Program # P1-02-03.

• Significance of GRB7 protein expression level in breast cancer. Brandon D Ellsworth, David J Dabbs, Rohit Bhargava. Publication number 148. Presented at the 102nd Annual United States and Canadian Academy of Pathology Meeting. March 2-8, 2013. Baltimore, MD.

• Immunohistochemical Profile of Breast Cancer With Respect To ER and HER2 Status. Nika Gloyeske, Esther Elishaev, David J Dabbs, Anna H Woodard, Jing Yu, Rohit Bhargava. Publication number 171. Presented at the 102nd Annual United States and Canadian Academy of Pathology Meeting. March 2-8, 2013. Baltimore, MD.

• Low ER+ Breast Cancer: Is this a distinct group? Nika Gloyeske, David J Dabbs, Rohit Bhargava. Publication number 172. Presented at the 102nd Annual United States and Canadian Academy of Pathology Meeting. March 2-8, 2013. Baltimore, MD.

• DPC4 Immunostaining In Mullerian Tumors With And Without Mucinous Differentiation. Esther Elishaev MD, Xin Li MD, PhD, Amal Kanbour-Shakir MD, PhD, Sarah E Taylor MD, Robert P Edwards MD, Jing Yu MD, PhD, Anna H Woodard MD, Mirka W Jones MD, and Rohit Bhargava MD. Publication number 1133. Presented at the 102nd Annual United States and Canadian Academy of Pathology Meeting. March 2-8, 2013. Baltimore, MD.

• PTEN and P16 expression highlights atypia and malignant transformation in smooth muscle tumors of the uterus. Mirka W Jones, Rohit Bhargava, Agnieszka Onisko, Giuliana Trucco. Publication number 1174. Presented at the 102nd Annual United States and Canadian Academy of Pathology Meeting. March 2-8, 2013. Baltimore, MD.

• Evaluation of Image Analysis for Interpretation of Her-2 Dual in situ Hybridization (DISH). Jeffery L Fine, David J Dabbs, Kim McManus, Rohit Bhargava. Publication number 1577. Presented at the 102nd Annual United States and Canadian Academy of Pathology Meeting. March 2-8, 2013. Baltimore, MD.

• Impact of different antibody clones on Ki-67 labeling index assessment in breast carcinoma. Beth Z Clark, David J Dabbs, Mohahmed Desouki, Rohit Bhargava. Publication number 1968. Presented at the 102nd Annual United States and Canadian Academy of Pathology Meeting. March 2-8, 2013. Baltimore, MD.

• Impact of 96 hours formalin fixation on assessment of Ki-67 labeling index. Beth Z Clark, David J Dabbs, Mohamed Desouki, Rohit Bhargava. Publication number 1969. Presented at the 102nd Annual United States and Canadian Academy of Pathology Meeting. March 2-8, 2013. Baltimore, MD.

• Repeat of Estrogen Receptor (ER) on Breast Resection Specimens with “Low ER” on Core Biopsy – Is it Worth Repeating? Nika Gloyeske, David J Dabbs, Rohit Bhargava. Publication number 1978. Presented at the 102nd Annual United States and Canadian Academy of Pathology Meeting. March 2-8, 2013. Baltimore, MD.

• Should all endometrial tumors be tested for MSI by IHC? A Pilot analysis. Amal Kanbour-Shakir, Rohit Bhargava, David J Dabbs, Esther Elishaev. Publication number 1983. Presented at the 102nd Annual United States and Canadian Academy of Pathology Meeting. March 2-8, 2013. Baltimore, MD.

• The Ventana INFORM HER2 dual in situ hybridization (DISH) DNA probe cocktail assay versus fluorescence in situ hybridization (FISH): Focused study of immunohistochemical 2+ cases. Faye F Gao, David J Dabbs, Rohit Bhargava. Publication number 2051. Presented at the 102nd Annual United States and Canadian Academy of Pathology Meeting. March 2-8, 2013. Baltimore, MD.

• A proteomic analysis of surgical cytoreduction in patients with advanced ovarian cancer. Jamie L Lesnock, Brian L Hood, Mai sun, Rohit Bhargava, Thomas P Conrads, Thomas C Krivak. 2012 ASCO Annual Meeting. J Clin Oncol 30: 2012 (suppl; abstr e15560).

• Single institution experience with neoadjuvant chemotherapy for metaplastic breast cancer (MBC). Anna Kaminsky, Rohit Bhargava, Kandace P McGurie, Shannon Puhalla. 2012 ASCO Annual Meeting. J Clin Oncol 30: 2012 (suppl; abstr 1038).

• Metallothionein expression and outcome in patients with metastatic breast cancer (MBC). Jorge Arturo Rios-Perez, Sameem Abedin, Margaret Quinn Rosenzweig, Su Yon Jung, Rohit Bhargava. 2012 ASCO Annual Meeting. J Clin Oncol 30: 2012 (suppl; abstr 1085).

• Predicting success of breast conservation after neoadjuvant chemotherapy: what factors affect surgical outcome? Diego, Emilia; McGuire, Kandace P; Soran, Atilla; Zuley, Margarita; Bhargava, Rohit; Bonaventura, Marguerite; Johnson, Ronald; Ahrendt,

Gretchen M. 2012 Annual Meeting of the Society for Surgical Oncology. March 21-24, 2012. Orlando, FL. Abstract P86.

• Does trastuzumab containing neoadjuvant chemotherapy impact in situ carcinoma? Diego, Emilia; Ahrendt, Gretchen M; McGuire, Kandace P; Johnson, Ronald R; Badve, Preeti; Bhargava, Rohit. 2012 Annual Meeting of the Society for Surgical Oncology. March 21-24, 2012. Orlando, FL. Abstract P52.

• Intra-Operative Margin Evaluation Of Breast Specimens: Value Of Gross Evaluation. Abbie R Mallon, David J Dabbs, Ronald R Johnson, Gretchen M Ahrendt, Kandace P McGuire, Marguerite Bonaventura and Rohit Bhargava. Annual Meeting, United States and Canadian Academy of Pathology, Vancouver, BC. March 17-23, 2012. Abstract 206. Mod Pathol 2012. 25(S2):52A.

• Breast Angiosarcoma: A Clinicopathologic Study. Anca V Florea, David J Dabbs, Sushil Beriwal, Rohit Bhargava. Annual Meeting, United States and Canadian Academy of Pathology, Vancouver, BC. March 17-23, 2012. Abstract 150. Mod Pathol 2012. 25(S2):39A.

• Inter-Observer Agreement Among Pathologists For Semi-Quantitative Hormone Receptor Scoring In Breast Carcinoma. David Cohen, David J Dabbs, Kristine L Cooper, Milon Amin, Terrell E Jones, Mirka W Jones, Mamatha Chivukula, Giuliana A Trucco, Rohit Bhargava. Annual Meeting, United States and Canadian Academy of Pathology, Vancouver, BC. March 17-23, 2012. Abstract 117. Mod Pathol 2012. 25(S2):31A.

• Predictors Of Response To Standard Neoadjuvant Chemotherapy In Estrogen Receptor Positive, HER2 Negative Breast Cancer. Rohit Bhargava. Annual Meeting, United States and Canadian Academy of Pathology, Vancouver, BC. March 17-23, 2012. Abstract 194. Mod Pathol 2012. 25(S2):26A.

• Cytokeratin Profile of Breast Carcinoma: Do CK7 negative breast carcinoma exist? Esther Elishaev and Rohit Bhargava. Annual Meeting, United States and Canadian Academy of Pathology, Vancouver, BC. March 17-23, 2012. Abstract 141. Mod Pathol 2012. 25(S2):37A.

• Breast Carcinoma Ki-67 Labeling Index: Comparison between Image Analysis and Expert Human Scoring with Discussion about Choosing Tumor Areas to Analyze. Jeffrey L Fine MD, David J Dabbs MD, Kristine L Cooper MS and Rohit Bhargava MD. Annual Meeting, United States and Canadian Academy of Pathology, Vancouver, BC. March 17-23, 2012. Abstract 1636. Mod Pathol 2012. 25(S2):391A.

• The Effect of 96-Hour Formalin Fixation on the Immunohistochemical Evaluation of Estrogen Receptor (ER), Progesterone Receptor (PR), and HER2 Expression in Invasive Breast Cancer. Isil Yildiz, David J Dabbs, Mamatha Chivukula, Rohit Bhargava. Annual Meeting, United States and Canadian Academy of Pathology, Vancouver, BC. March 17-23, 2012. Abstract 303. Mod Pathol 2012. 25(S2):75A.

• Impact of Cold Ischemic Time on Estrogen Receptor, Progesterone Receptor, and HER2 Semi-quantitative Immunohistochemical Scoring. Isil Z Yildiz-Aktas MD, David J Dabbs MD and Rohit Bhargava MD. Annual Meeting, United States and Canadian Academy of Pathology, Vancouver, BC. March 17-23, 2012. Abstract 304. Mod Pathol 2012. 25(S2):75A.

• How Often Does Positive Peritoneal Wash Cytology Independently Upstage and Impact Clinical Management of Ovarian Malignancies? Jing Yu, Rohit Bhargava, R. Marshall Austin. Annual Meeting, United States and Canadian Academy of Pathology, Vancouver, BC. March 17-23, 2012. Abstract 1274. Mod Pathol 2012. 25(S2):303A.

• Inter-Observer Agreement Among Pathologists For Assessing Ki-67 Labeling Index On Whole Slides and “Hot Spots” In Breast Carcinomas. Milon Amin, David Cohen, David J Dabbs, Kristine L Cooper, Terrell E Jones, Mirka Jones, Guiliana A Trucco, Mamatha Chivukula, Rohit Bhargava. Annual Meeting, United States and Canadian Academy of Pathology, Vancouver, BC. March 17-23, 2012. Abstract 89. Mod Pathol 2012. 25(S2):24A.

• Prediction of Oncotype DX Recurrence Score: Use of Equations Derived by Linear Regression Analysis. Molly E Klein MD, David J Dabbs MD, Yongli Shuai MS and Rohit Bhargava MD. Annual Meeting, United States and Canadian Academy of Pathology, Vancouver, BC. March 17-23, 2012. Abstract 182. Mod Pathol 2012. 25(S2):46A.

• Predictors of response to trastuzumab-containing neoadjuvant chemotherapy in HER2 positive breast cancer. Xin Li M.D., Ph.D., Amal Kanbour-Shakir M.D., Ph.D., David Dabbs M.D. and Rohit Bhargava M.D. Annual Meeting, United States and Canadian Academy of Pathology, Vancouver, BC. March 17-23, 2012. Abstract 194. Mod Pathol 2012. 25(S2):49A.

• Pelvic high grade serous carcinoma and association with serous tubal intraepithelial carcinoma. Huaitao Yang, Rohit Bhargava, Xiangbai Cheng, Faye Gao, Zaibo Li, Chengquan Zhao. Annual Meeting, United States and Canadian Academy of Pathology, Vancouver, BC. March 17-23, 2012. Abstract 1272. Mod Pathol 2012. 25(S2):302A.

• Characteristic Features of Serous Tubal Intraepithelial Carcinoma and Its Co-Existing Invasive Carcinomas. Faye Gao, Huaitao Yang, Rohit Bhargava, Xiangbai Cheng, Zaibo Li, Chengquan Zhao. Annual Meeting, United States and Canadian Academy of Pathology, Vancouver, BC. March 17-23, 2012. Abstract 1139. Mod Pathol 2012. 25(S2):272A.

• Multicenter quality assurance profile review of lobular breast carcinomas versus the 21 gene recurrence score: assessment of clinical relevance. David J Dabbs, David Hicks, Raymond R Tubbs, Adam Brufsky, Rohit Bhargava. 2011 San Antonio Breast Cancer Symposium. December 6-10, 2011.Program # P4-09-22.

• Consistent high false negative rate of HER2 qRT-PCR of oncotype DX® in comparison to ASCO/CAP recommended combined IHC/FISH method. David J Dabbs and Rohit Bhargava. 2011 San Antonio Breast Cancer Symposium. December 6-10, 2011. Program # P1-07-20.

• Impact of progesterone receptor semiquantitative immunohistochemical result on oncotype DX recurrence score: A quality assurance study of 1078 cases. Rohit Bhargava and David J Dabbs. 2011 San Antonio Breast Cancer Symposium. December 6-10, 2011. Program # P5-14-08.

• High false-negative rate of HER2 qRT-PCR of the Oncotype DX test: An independent quality assurance study. D. J. Dabbs, M. Klein, S. Mohsin, R. R. Tubbs, R. Bhargava. 2011 ASCO Annual Meeting. J Clin Oncol 29: 2011 (suppl; abstr 603).

• NYBR1 Expression in Breast and Gynecologic Tract Carcinomas. Anna Woodard, Jing Yu, David Dabbs, Anca Florea, Sushil Beriwal and Rohit Bhargava. United States and Canadian Academy of Pathology, San Antonio, TX. February 26-March 4, 2011.

• PAX8 Expression in Gynecologic and Breast Carcinoma. Jing Yu, Anna H. Woodard, Anca V. Florea, David J. Dabbs, Sushil Beriwal and Rohit Bhargava. United States and Canadian Academy of Pathology, San Antonio, TX. February 26-March 4, 2011.

• Basal Marker Reactivity in Triple Negative Breast Carcinomas Does Not Predict Pathologic Complete Response Following Neoadjuvant Chemotherapy. James Kraus, Sushil Beriwal, David Dabbs, Rohit Bhargava. United States and Canadian Academy of Pathology, San Antonio, TX. February 26-March 4, 2011.

• Validation Study of Hormone Receptor Status in Breast Ductal Carcinoma In Situ by Quantum Dot Multispectral Imaging System. Jing Yu MD PhD, Sara E. Monaco MD, Rohit Bhargava MD, David J. Dabbs MD, Kathleen M. Cieply BS, Jeff L. Fine MD PhD. United States and Canadian Academy of Pathology, San Antonio, TX. February 26-March 4, 2011.

• Endometrial Adenosarcomas: Diagnostic Use of Ki-67 Proliferation Marker As An Adjunct To Morphologic Diagnosis. Nidhi Agarwal, Rohit Bhargava, Esther Elishaev. United States and Canadian Academy of Pathology, Washington, D.C. March 20-26, 2010. Mod Pathol. 2010;23 (Supplement 1): Abstract 1037.

• Human Epidermal Growth Factor Receptor 2 (HER2) status determination using single color versus dual color fluorescence in-situ hybridization (FISH) assay: Impact of monosomy and polysomy 17. LA Niemeier, D Dabbs, U Surti, K Cieply, J Yu and R Bhargava. United States and Canadian Academy of Pathology, Washington, D.C. March 20-26, 2010. Mod Pathol. 2010;23 (Supplement 1): Abstract 275.

• Triple Positive Breast Carcinomas: Is Oncotype Dx™ Test Justified? E Marchetti, R Bhargava and DJ Dabbs. United States and Canadian Academy of Pathology, Washington, D.C. March 20-26, 2010. Mod Pathol. 2010;23 (Supplement 1): Abstract 265.

• Luminal A versus Luminal B Tumors: Significance of Proliferation Index in ER Positive HER2 Negative Tumors. E Marchetti, D Dabbs, J Yu, S Beriwal and R Bhargava. United States and Canadian Academy of Pathology, Washington, D.C. March 20-26, 2010. Mod Pathol. 2010;23 (Supplement 1): Abstract 264.

• Validation of the Magee Study Equation in Prediction of Breast Cancer Recurrence Risk Category by oncotype Dx™. NN Esposito, G Acs, DJ Dabbs, M Flanagan, C Laronga and R Bhargava. United States and Canadian Academy of Pathology, Washington, D.C. March 20-26, 2010. Mod Pathol. 2010;23 (Supplement 1): Abstract 192.

• Semi-Quantitative Estrogen Receptor Expression Level Influences Response To Trastuzumab Containing Neo-Adjuvant Chemotherapy In HER2 Positive Tumors. Rohit Bhargava, David J Dabbs, Sushil Beriwal, Ronald R Johnson, Adam M Brufsky, Barry Lembersky, Atilla Soran and Gretchen M Ahrendt. United States and Canadian Academy of Pathology, Washington, D.C. March 20-26, 2010. Mod Pathol. 2010;23 (Supplement 1): Abstract 156.

• Estimation of risk of recurrence of early stage estrogen receptor positive (ER+) breast carcinoma (BC) by pathologists compared to the Oncotype Dx Recurrence Score. A multi-institutional study. Acs, G., Esposito, Reynolds, C., Lawton, T.J., Bleiweiss, I., Nagi, C., Ioffe, O., Hameed, O., Dabbs, D., Bhargava, R., Quddus, M.R., Sung, C.J., Gilcreast, M., Sapino, A., Cserni, G., Jacquemier, J., Kulka, J., Regitnig, P., Baas, I., van Diest, P. and Quinn, C. United States and Canadian Academy of Pathology, Washington, D.C. March 20-26, 2010. Mod Pathol. 2010;23 (Supplement 1): Abstract 130.

• IGF-1R expression in normal breast tissue, benign, proliferative, in-situ breast lesions and invasive breast carcinoma. Rohit Bhargava, MD, Sushil Beriwal, MD, David J Dabbs, MD. Presented at the 32nd Annual San Antonio Breast Cancer Symposium, San Antonio, TX. December 9-13, 2009. Program # 3051. Cancer Res 2009;69(Suppl.):(24). December 15, 2009.

• Pregnancy Related Breast Carcinoma: Comparison of Receptor Status with Age-Matched Controls. Rohit Bhargava, MD, Paniti Sukumvanich, MD, Sushil Beriwal, MD. Presented at the 32nd Annual San Antonio Breast Cancer Symposium, San Antonio, TX. December 9-13, 2009. Program # 6012. Cancer Res 2009;69(Suppl.):(24). December 15, 2009.

• Breast Cancer Molecular Class ERBB2: Preponderance of Tumors with Apocrine Differentiation and Expression of Basal Phenotype Markers CK5, CK5/6 and EGFR. R Bhargava, JM Striebel, DJ Dabbs. Annual Meeting, United States and Canadian Academy of Pathology, boston, MA. March 7-13, 2009. Mod Pathol. 2009;22 (Supplement 1): Abstract 122.

• Concordance between Semi-Quantitative Immunohistochemical Assay and oncotypeDX RT-PCR Assay for Estrogen and Progesterone Receptors. R Bhargava, S Beriwal, DJ

Dabbs. Annual Meeting, United States and Canadian Academy of Pathology, boston, MA. March 7-13, 2009. Mod Pathol. 2009;22 (Supplement 1): Abstract 123.

• 'Flat Epithelial Atypia': Impact of the Entity with Reference to Number of Levels Obtained on the Paraffin Embedded Blocks of the Breast Core Needle Biopsies. M Chivukula, R Bhargava, G Tseng, DJ Dabbs. Annual Meeting, United States and Canadian Academy of Pathology, boston, MA. March 7-13, 2009. Mod Pathol. 2009;22 (Supplement 1): Abstract 138.

• Hormone Receptor Immunohistochemistry: The Prevalence of ER-PR+ Results Are PR Antibody Clone-Dependent. DC Gingell, R Bhargava, DJ Dabbs. Annual Meeting, United States and Canadian Academy of Pathology, boston, MA. March 7-13, 2009. Mod Pathol. 2009;22 (Supplement 1): Abstract 178.

• Detailed FISH Analysis of HER2 2+ Immunohistochemistry Cases: Rarity of Cases with High Level HER2 Gene Amplification. DC Gingell, DJ Dabbs, U Surti, R Bhargava. Annual Meeting, United States and Canadian Academy of Pathology, boston, MA. March 7-13, 2009. Mod Pathol. 2009;22 (Supplement 1): Abstract 179.

• Basal-Like Breast Carcinoma: Identifying Estrogen Receptor Positive Cases. DC Gingell, S O'Connor, R Bhargava, DJ Dabbs. Annual Meeting, United States and Canadian Academy of Pathology, boston, MA. March 7-13, 2009. Mod Pathol. 2009;22 (Supplement 1): Abstract 180.

• Androgen Receptor Expression in Breast Cancer Molecular Classes: An Immunohistochemical Study of 190 Consecutive Cases. LA Niemeier, DJ Dabbs, JM Striebel, R Bhargava. Annual Meeting, United States and Canadian Academy of Pathology, boston, MA. March 7-13, 2009. Mod Pathol. 2009;22 (Supplement 1): Abstract 259.

• Expression of Gamma-Laminin, Cytokeratin 5 and Cytokeratin 5/6 in Metaplastic and Basal-like Breast Carcinomas. SM O'Connor, L Niemeier, R Bhargava, WT Parks, DJ Dabbs. Annual Meeting, United States and Canadian Academy of Pathology, boston, MA. March 7-13, 2009. Mod Pathol. 2009;22 (Supplement 1): Abstract 264.

• Computer-aided detection of HER2 amplification status using FISH images: a preliminary study. Bin Zheng, Xiao-Hui Wang, Urvashi surti, Rohit Bhargava, David Gur. SPIE Paper # 7260-78 presented at the “Computer Aided Diagnosis” conference as part of the SPIE Symposium on Medical Imaging. February 7-12, 2009 in Lake Buena Vista, Florida USA. (http://spie.org/Documents/ConferencesExhibitions/Medical-Imaging-2009-Advance.pdf).

• Breast Cancer Molecular Classification Using Immunohistochemical Surrogate Markers Predicts Response to Neoadjuvant Chemotherapy. Rohit Bhargava, Faith Goldman, Sushil Beriwal, David J Dabbs, Ronald Johnson, Adam M Brufsky, Barry C Lembersky and Gretchen M Ahrendt. Presented at the 31st Annual San Antonio Breast Cancer Symposium, San Antonio, TX. December 10-14, 2008. Program # 6071

• ALDH1 Expression in Human Breast Carcinoma. Rohit Bhargava, Sushil Beriwal, Kim McManus, and David J Dabbs. Presented at the 31st Annual San Antonio Breast Cancer Symposium, San Antonio, TX. December 10-14, 2008. Program # 5057.

• Clinical significance of the entity ‘flat epithelial atypia’ on core needle biopsies of breast. Dabbs DJ, Bhargava R, Tseng G, Chivukula M. Presented at the 31st Annual San Antonio Breast Cancer Symposium, San Antonio, TX. December 10-14, 2008. Program # 3006.

• Identification of biomarkers associated with metastatic breast cancer to bone by immunohistochemistry on tissue microarrays. Nasir I, Brufsky A, Bhargava R, McManus K, Chivukula M. Presented at the 31st Annual San Antonio Breast Cancer Symposium, San Antonio, TX. December 10-14, 2008. Program # 2065.

• The value of immunohistochemistry in distinction between endocervical adenocarcinoma and adenocarcinoma of endometrium, endometrioid type. A comparative tissue microarray study of 76 cases. MW Jones, A Onisko, DJ Dabbs, E Elishaev and R Bhargava. International Academy of Pathology, Athens, Greece. October 12-19, 2008. Histopathol. 2008;53 (supplement 1):1-432. Abstract 427.

• The value of CD10, caldesmon, and D2-40 in evaluation of myometrial invasion in adenocarcinoma of the endometrium. A study of 45 cases. Jones MW, Trucco G, Bhargava R. International Academy of Pathology, Athens, Greece. October 12-19, 2008. Histopathol. 2008;53 (supplement 1):1-432. Abstract 426.

• Ki-67 labeling index in breast carcinoma: An immunohistochemical study with correlation to molecular subtypes. Rohit Bhargava, Joan Striebel, Agnieszka Onisko, Kim McManus, David J Dabbs. J Clin Oncol. 2008;26:May 20 supplement-Abstract 22107.

• CK5 Is More Sensitive Than CK5/6 In Identifying “Basal-like” Carcinoma Of The Breast. R Bhargava and DJ Dabbs. Annual Meeting, United States and Canadian Academy of Pathology, Denver, CO. March 1-7, 2008. Mod Pathol. 2008;21 (Supplement 1): 23A, Abstract 92.

• The Dynamic Biology Of E-Cadherin And P120 Catenin: Development Of A Dual Immunostain For Diagnostic Use In Breast Pathology. R Bhargava, D Tast, T Ewing-Finchem, K Obrecht, and DJ Dabbs. Annual Meeting, United States and Canadian Academy of Pathology, Denver, CO. March 1-7, 2008. Mod Pathol. 2008;21 (Supplement 1): 23A, Abstract 93.

• Fixation Issues With Breast Carcinoma Hormone Receptors: ER Negative PR Positive Carcinomas Exist Even With Optimal Fixation Methods. DJ Dabbs, GJ Carter, R Bhargava. Annual Meeting, United States and Canadian Academy of Pathology, Denver, CO. March 1-7, 2008. Mod Pathol. 2008;21 (Supplement 1): 27A, Abstract 111.

• Best Practices In Breast Pathology: Practical Quality Assurance/Patient Safety Program In A Women’s Hospital. A Descriptive Study. DJ Dabbs, GJ Carter, MW Jones, R Bhargava. Annual Meeting, United States and Canadian Academy of Pathology, Denver, CO. March 1-7, 2008. Mod Pathol. 2008;21 (Supplement 1): 355A, Abstract 1619.

• Use of PAX-2 antibody to distinguish metastatic ovarian serous papillary carcinoma from primary breast carcinoma. S O’Connor, R Bhargava, DJ Dabbs, M Chivukula. Annual Meeting, United States and Canadian Academy of Pathology, Denver, CO. March 1-7, 2008. Mod Pathol. 2008;21 (Supplement 1): 216A, Abstract 986.

• WT-1 Expression In Primary Mucinous Carcinomas Of The Breast. AB Domfeh, AM Carley, J Striebel, A Florea, RG Karabakhtsian and R Bhargava. Annual Meeting, United States and Canadian Academy of Pathology, Denver, CO. March 1-7, 2008. Mod Pathol. 2008;21 (Supplement 1): 28A, Abstract 118.

• The Borderline Amplified HER2 FISH Result on Breast Core Biopsy: Indications for Further Sampling Do Affect Patient Management. Joan M Striebel, Rohit Bhargava, Adam Brufsky, Urvashi Surti, David J Dabbs. San Antonio Breast Cancer Sym